# Chronic Kidney Disease > This is general, educational information — not individualized medical advice, and not a substitute for your care team. For decisions about your own health, or in an emergency, contact your doctor or local emergency services. A long-term condition in which the kidneys are damaged or filter less well than they should — defined and tracked by eGFR and albuminuria (ACR), staged G1–G5 — spanning early, often silent disease through kidney failure treated with dialysis or transplant. ## In this guide - Overview & Classification - CKD Stages (G1–G5 and A1–A3) - Causes & Pathophysiology - Diagnosis & Testing - Acute Emergencies & Red Flags - Treatments & Medications - Dialysis & Transplant - Nutrition & the CKD Diet - Therapies & Lifestyle - Patient Care & Self-Management - Complications of CKD - Key Drug Interactions - Comorbidities & Co-occurring Conditions - Experimental & Emerging Therapies - Complementary & Integrative Approaches --- ## Overview & Classification What chronic kidney disease is, how common and often silent it is, the two key measures (eGFR and albuminuria/ACR), and the range from early CKD to kidney failure (end-stage kidney disease). ### What chronic kidney disease is **Chronic kidney disease (CKD) means the kidneys are damaged or filtering less well than they should, and the problem has persisted for at least three months.** The kidneys are two fist-sized organs that filter waste and extra fluid from the blood into urine, balance minerals and acids, control blood pressure, and make hormones that support red blood cells and bone health. Chronic kidney disease means this filtering ability is reduced, or there is evidence of kidney damage (such as protein leaking into the urine), and the abnormality has lasted at least three months — the 'chronic' part distinguishing it from a sudden, often reversible drop called acute kidney injury. CKD is usually progressive and, in its early stages, causes few or no symptoms, which is why it is often called a 'silent' disease and frequently goes undiagnosed. It is defined and tracked by two numbers: an estimate of how fast the kidneys filter (eGFR) and how much protein (albumin) leaks into the urine (the albumin-to-creatinine ratio, or ACR). Catching CKD early matters because steps taken before symptoms appear can slow it down and protect the heart as well as the kidneys. **Sources:** - [Chronic Kidney Disease (CKD)](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd) — NIH / NIDDK - [What Is Chronic Kidney Disease?](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/what-is-chronic-kidney-disease) — NIH / NIDDK ### How common — and how often undiagnosed — CKD is **CKD affects more than 1 in 7 U.S. adults, and most people who have it do not know, because early CKD usually causes no symptoms.** Chronic kidney disease is far more common than most people realize: it affects more than one in seven U.S. adults — roughly 35 million people — according to national surveillance data. Strikingly, the large majority of people with CKD are unaware they have it, because the early stages typically produce no noticeable symptoms; problems like fatigue, swelling, or changes in urination often appear only once the disease is advanced. This combination of high prevalence and silence is why testing matters for people at higher risk — particularly those with diabetes, high blood pressure, heart disease, obesity, a family history of kidney failure, or who are older. Because CKD also sharply raises the risk of heart attack, stroke, and early death, finding it early is valuable not only for the kidneys but for overall health. Simple blood and urine tests can detect it long before symptoms begin. **Sources:** - [Kidney Disease Statistics for the United States](https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease) — NIH / NIDDK - [Chronic Kidney Disease in the United States](https://www.cdc.gov/kidney-disease/php/data-research/index.html) — CDC ### The two key measures: eGFR and albuminuria (ACR) **CKD is defined and staged by two numbers — eGFR, which estimates filtering speed, and the urine albumin-to-creatinine ratio (ACR), which measures protein leaking into the urine.** Two measurements anchor everything in CKD. The first is the estimated glomerular filtration rate (eGFR), a calculation from a blood creatinine level (plus age and sex) that estimates how many milliliters of blood the kidneys filter per minute; a normal value is around 90 or above, and a value persistently below 60 suggests reduced kidney function. The second is albuminuria, usually reported as the urine albumin-to-creatinine ratio (ACR), which measures how much of a protein called albumin is leaking into the urine — healthy kidneys keep albumin in the blood, so its appearance in urine is an early sign of kidney damage, often before eGFR falls. These two measures are complementary: eGFR shows how well the kidneys are filtering, while ACR shows whether the filters are damaged and leaking, and a person can have abnormal albuminuria with a still-normal eGFR. Together they define whether CKD is present, how advanced it is, and how fast it is likely to progress, which is why modern staging uses both. **Sources:** - [Estimated GFR (eGFR)](https://www.kidney.org/kidney-topics/estimated-glomerular-filtration-rate-egfr) — National Kidney Foundation - [Chronic Kidney Disease Tests & Diagnosis](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/tests-diagnosis) — NIH / NIDDK ### What healthy kidneys do (and what fails in CKD) **Beyond filtering waste, the kidneys balance fluid and minerals, control blood pressure, keep blood from getting too acidic, and make hormones for red blood cells and bone — so CKD affects far more than waste removal.** Understanding CKD's wide-ranging effects starts with appreciating everything healthy kidneys do. They filter waste products (such as urea and creatinine) and excess fluid from the blood; balance electrolytes like sodium, potassium, and phosphorus; regulate the body's acid-base balance; help control blood pressure through fluid balance and hormones; activate vitamin D to keep bones healthy; and produce erythropoietin, a hormone that signals the bone marrow to make red blood cells. As CKD advances and these functions decline, the consequences spread well beyond waste buildup: blood pressure tends to rise, potassium and phosphorus can climb to dangerous levels, the blood can become too acidic, bones can weaken (CKD–mineral and bone disorder), and anemia can develop from too little erythropoietin. This explains why CKD care addresses blood pressure, minerals, bone, and blood counts — not just filtration — and why complications can appear before kidney failure itself. **Sources:** - [Your Kidneys & How They Work](https://www.niddk.nih.gov/health-information/kidney-disease/kidneys-how-they-work) — NIH / NIDDK - [How Your Kidneys Work](https://www.kidney.org/kidney-topics/kidney-function) — National Kidney Foundation ### From early CKD to kidney failure **CKD spans a wide range — from mild, symptomless disease that may never progress far, to kidney failure (end-stage kidney disease) that requires dialysis or a transplant to sustain life.** Chronic kidney disease is a spectrum, not a single state. Many people have mild CKD that progresses slowly or not at all, especially when blood pressure, blood sugar, and albuminuria are well managed, and they may live a normal lifespan without ever reaching kidney failure. At the other end, CKD can advance to kidney failure — also called end-stage kidney disease (ESKD) or stage G5 — in which the kidneys can no longer filter enough to keep a person well, and treatment with dialysis or a kidney transplant becomes necessary to survive. Whether and how fast someone moves along this spectrum depends on the underlying cause, the degree of albuminuria, blood pressure and glucose control, and other factors, and it varies widely between individuals. Importantly, progression is not inevitable: modern treatments can slow or even halt decline for many people, which is why early diagnosis and consistent management are so valuable. The goal of CKD care is to keep people as far from kidney failure as possible for as long as possible. **Sources:** - [Kidney Failure (ESRD) — Symptoms, Stages & Treatment](https://www.kidney.org/kidney-topics/kidney-failure) — National Kidney Foundation - [Managing Chronic Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/managing) — NIH / NIDDK --- ## CKD Stages (G1–G5 and A1–A3) How CKD is classified — the five GFR categories (G1–G5) crossed with the three albuminuria categories (A1–A3) under the KDIGO framework — and what the stages mean for monitoring and risk. ### The GFR stages: G1 to G5 **CKD is divided into five GFR categories, from G1 (normal filtering with kidney damage) down to G5 (kidney failure, eGFR under 15).** The most familiar part of CKD staging is the GFR category, which ranges from G1 to G5 based on the estimated glomerular filtration rate. G1 means an eGFR of 90 or above (normal or high filtering) but with some marker of kidney damage, such as albuminuria; G2 is 60–89 (mildly reduced) again with a damage marker; G3a is 45–59 and G3b is 30–44 (mild-to-moderate and moderate-to-severe reduction); G4 is 15–29 (severely reduced); and G5 is below 15, which is kidney failure. An important nuance is that a mildly reduced eGFR alone (G1 or G2 numbers) is not labeled CKD unless there is also evidence of kidney damage, because filtering can dip modestly with normal aging. The stages matter because they guide how often kidney function is checked, when to involve a kidney specialist (nephrologist), and when to begin planning for possible dialysis or transplant. They describe current function, not a fixed destiny — many people remain stable for years. **Sources:** - [Estimated Glomerular Filtration Rate (eGFR) and Kidney Disease Stages](https://www.kidney.org/kidney-failure-risk-factor-estimated-glomerular-filtration-rate-egfr) — National Kidney Foundation - [What Is Chronic Kidney Disease?](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/what-is-chronic-kidney-disease) — NIH / NIDDK ### The albuminuria stages: A1 to A3 **Alongside GFR, CKD is graded by how much albumin leaks into the urine — A1 (normal to mildly increased), A2 (moderately increased), and A3 (severely increased).** The second dimension of CKD staging is albuminuria, measured by the urine albumin-to-creatinine ratio (ACR) and divided into three categories. A1 means an ACR under 30 mg/g (normal to mildly increased); A2 means 30–300 mg/g (moderately increased, historically called 'microalbuminuria'); and A3 means above 300 mg/g (severely increased, historically 'macroalbuminuria'). More albumin in the urine signals more kidney damage and predicts faster progression and higher cardiovascular risk — often independently of the eGFR. This is why a person can have a normal eGFR but still have meaningful CKD if albuminuria is present, and why reducing albuminuria (for example with certain blood-pressure and diabetes medicines) is a key treatment goal in its own right. Because a single urine sample can be affected by exercise, infection, or other factors, an abnormal result is usually confirmed on repeat testing before it is acted on. **Sources:** - [Albuminuria: Albumin in the Urine](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/tests-diagnosis/albuminuria-albumin-urine) — NIH / NIDDK - [Urine Albumin-to-Creatinine Ratio (uACR)](https://www.kidney.org/kidney-topics/urine-albumin-creatinine-ratio-uacr) — National Kidney Foundation ### Why both numbers are used together (the KDIGO 'heat map') _(Established)_ **Modern staging combines GFR and albuminuria into a single risk grid — the KDIGO 'heat map' — because the two together predict outcomes far better than either alone.** International KDIGO guidelines stage CKD using both the GFR category and the albuminuria category together, displayed as a color-coded grid often called the 'heat map.' The grid runs from green (lowest risk) through yellow and orange to red (highest risk), with risk rising as eGFR falls and as albuminuria increases. Combining the two matters because they capture different things — how well the kidneys filter and how damaged the filters are — and together they predict progression to kidney failure, cardiovascular events, and death much better than GFR alone. In practice, this means two people with the same eGFR can be in very different risk zones depending on their albuminuria, and the heat map helps the care team decide how aggressively to treat blood pressure, when to start kidney-protective medicines, how often to monitor, and when to refer to a nephrologist. The framework is a tool for tailoring care intensity, not a label that fixes a person's future. **Sources:** - [KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD](https://kdigo.org/guidelines/ckd-evaluation-and-management/) — KDIGO, 2024 - [Identify & Evaluate Patients with Chronic Kidney Disease](https://www.niddk.nih.gov/health-information/professionals/clinical-tools-patient-management/kidney-disease/identify-manage-patients/evaluate-ckd) — NIH / NIDDK ### Stage G5: kidney failure (end-stage kidney disease) **G5 means an eGFR below 15 — the kidneys can no longer filter enough on their own, and dialysis or transplant is usually needed, though the timing is individualized.** Stage G5 CKD, an eGFR below 15, represents kidney failure, also called end-stage kidney disease (ESKD) or end-stage renal disease. At this level the kidneys can no longer remove enough waste and fluid to keep a person healthy, and symptoms of advanced disease — fatigue, nausea, poor appetite, swelling, itching, and difficulty concentrating — become more likely. Most people at this stage will need kidney replacement therapy (dialysis or a transplant) to survive, although the exact timing of starting dialysis is based on symptoms, laboratory trends, and the individual rather than the eGFR number alone, and some carefully selected people choose conservative (non-dialysis) management focused on comfort. Crucially, the months before reaching G5 are when planning happens: choosing a treatment path, preparing dialysis access or pursuing a pre-emptive transplant, and getting education and support. Reaching advanced CKD is not a sudden emergency for most people but a transition that, when planned for in advance, can be navigated far more smoothly. **Sources:** - [Kidney Failure (ESRD) — Symptoms, Stages & Treatment](https://www.kidney.org/kidney-topics/kidney-failure) — National Kidney Foundation - [Choosing a Treatment for Kidney Failure](https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/choosing-treatment) — NIH / NIDDK ### How staging guides monitoring and referral **The stage determines how often kidney function is checked and when a nephrologist gets involved — earlier and more often as eGFR falls and albuminuria rises.** CKD staging is practical because it sets the rhythm of monitoring and the threshold for specialist involvement. In early, low-risk CKD (good eGFR, minimal albuminuria), kidney function may be checked roughly once a year, with the focus on controlling blood pressure and any diabetes and avoiding kidney injury. As the stage worsens — lower eGFR, higher albuminuria, or a rapidly falling trend — testing becomes more frequent, kidney-protective medicines are prioritized, and referral to a nephrologist is recommended (commonly around eGFR below 30, with significant albuminuria, rapid decline, or other red flags). Tracking the trend over time often matters more than any single value, because a steadily falling eGFR signals active disease that needs attention. Staging also triggers timely preparation for kidney failure when appropriate, so that decisions about dialysis or transplant are made calmly and in advance. The specific monitoring schedule for any individual is set by their care team based on their full risk picture. **Sources:** - [Managing Chronic Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/managing) — NIH / NIDDK - [KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD](https://kdigo.org/guidelines/ckd-evaluation-and-management/) — KDIGO, 2024 --- ## Causes & Pathophysiology Why kidneys become damaged — diabetes and high blood pressure as the leading causes, plus glomerular diseases, inherited conditions like polycystic kidney disease, obstruction, and the shared scarring pathway — and the main risk factors. ### Diabetes: the leading cause _(Established)_ **Diabetes is the most common cause of CKD; persistently high blood glucose damages the tiny filtering vessels of the kidney over years.** Diabetes is the single most common cause of chronic kidney disease, accounting for a large share of cases and of kidney failure. Over years, high blood glucose damages the kidney's millions of tiny filtering units (glomeruli) and the small blood vessels that supply them, a process called diabetic kidney disease or diabetic nephropathy. One of the earliest signs is albumin leaking into the urine, often before the eGFR falls, which is why people with diabetes are screened yearly with a urine ACR test as well as a blood eGFR. The good news is that this damage can be slowed substantially: tight-enough blood glucose control, blood-pressure control, and specific kidney-protective medicines (such as ACE inhibitors or ARBs, SGLT2 inhibitors, and finerenone) can meaningfully delay progression. Because diabetes, kidney disease, and heart disease are so tightly linked, protecting the kidneys in diabetes also protects the heart. **Sources:** - [Diabetic Kidney Disease](https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/diabetic-kidney-disease) — NIH / NIDDK - [Causes of Chronic Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/causes) — NIH / NIDDK ### High blood pressure: the second leading cause _(Established)_ **High blood pressure both causes and results from kidney disease, creating a damaging cycle; it is the second most common cause of CKD after diabetes.** High blood pressure (hypertension) is the second most common cause of chronic kidney disease, and it has a uniquely two-way relationship with the kidneys. Sustained high pressure damages and narrows the blood vessels in the kidneys, reducing their ability to filter; at the same time, damaged kidneys handle fluid and pressure-regulating hormones poorly, which raises blood pressure further — a self-reinforcing cycle that accelerates decline if not interrupted. Because of this, controlling blood pressure is one of the most powerful ways to slow CKD, and certain blood-pressure medicines (ACE inhibitors and ARBs) are favored because they protect the kidneys beyond their pressure-lowering effect, especially when albuminuria is present. Like early CKD, high blood pressure often causes no symptoms, so it can be quietly damaging the kidneys for years, which is why regular blood-pressure checks matter. Managing blood pressure protects not only the kidneys but also the heart and brain. **Sources:** - [High Blood Pressure & Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/high-blood-pressure) — NIH / NIDDK - [High Blood Pressure and Chronic Kidney Disease](https://www.kidney.org/high-blood-pressure-and-chronic-kidney-disease) — National Kidney Foundation ### Glomerular diseases (glomerulonephritis) **Diseases that inflame or scar the kidney's filters — the glomeruli — are an important cause of CKD, often signaled by blood or large amounts of protein in the urine.** The glomeruli are the kidney's microscopic filters, and a group of conditions called glomerular diseases (including various forms of glomerulonephritis) damage them directly. Some are caused by the immune system attacking the kidney (such as IgA nephropathy, lupus nephritis, and membranous nephropathy), some result from inflammation of small blood vessels (vasculitis), and others are linked to infections or other diseases. These conditions often announce themselves with blood in the urine, large amounts of protein in the urine (sometimes causing swelling, known as nephrotic syndrome), or a rising blood pressure and creatinine, and diagnosis frequently requires a kidney biopsy. Treatment depends on the specific disease and can include medicines that calm the immune system. Glomerular diseases are a leading cause of kidney failure in younger adults and an important reason that blood and protein in the urine should always be evaluated rather than ignored. **Sources:** - [Glomerular Diseases](https://www.niddk.nih.gov/health-information/kidney-disease/glomerular-diseases) — NIH / NIDDK - [Glomerulonephritis (GN)](https://www.kidney.org/kidney-topics/glomerulonephritis) — National Kidney Foundation ### Polycystic kidney disease and inherited causes **Polycystic kidney disease (PKD) is the most common inherited cause of kidney failure, in which fluid-filled cysts grow and gradually replace working kidney tissue.** Some kidney disease is inherited, and polycystic kidney disease (PKD) is the most common genetic cause of kidney failure. In the usual adult form (autosomal dominant PKD), a gene change causes many fluid-filled cysts to form and slowly enlarge in both kidneys over decades, expanding the kidneys and progressively crowding out and damaging healthy tissue, often leading to high blood pressure and, in many people, eventual kidney failure in mid-adulthood. Because it runs in families, a parent with PKD has a 50% chance of passing it to each child, and relatives may benefit from awareness and monitoring. Other inherited kidney diseases exist too, such as Alport syndrome. While inherited diseases cannot be prevented, controlling blood pressure and, for ADPKD, a specific medication (tolvaptan) in selected people can slow progression, and knowing the diagnosis helps with planning and family screening. A kidney specialist guides management of these conditions. **Sources:** - [Polycystic Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/polycystic-kidney-disease) — NIH / NIDDK - [Polycystic Kidney Disease (PKD)](https://www.kidney.org/kidney-topics/polycystic-kidney-disease) — National Kidney Foundation ### Obstruction, reflux, and other causes **Blockages to urine flow (such as an enlarged prostate, stones, or reflux), repeated infections, and certain medications or toxins can also damage the kidneys over time.** Beyond the major causes, several other problems can lead to chronic kidney disease. Anything that blocks the flow of urine and lets pressure build back up into the kidneys — an enlarged prostate, kidney stones, tumors, or congenital narrowings — can cause damage over time if not relieved; in children and some adults, urine flowing backward toward the kidneys (vesicoureteral reflux) and recurrent infections can scar the kidneys. Long-term use of certain medications and exposure to some toxins can injure the kidneys as well, including overuse of NSAID pain relievers, some herbal products, and certain other drugs. Less common causes include autoimmune diseases, recurrent kidney infections, and damage left behind after a severe episode of acute kidney injury, which can fail to fully recover. Identifying the specific cause matters because some are reversible (relieving an obstruction) and others guide targeted treatment, so an unexplained drop in kidney function is always worth investigating. **Sources:** - [Causes of Chronic Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/causes) — NIH / NIDDK - [Causes of Chronic Kidney Disease (CKD)](https://www.kidney.org/kidney-topics/chronic-kidney-disease-ckd) — National Kidney Foundation ### Who is at higher risk **Diabetes, high blood pressure, heart disease, a family history of kidney failure, older age, obesity, and certain ethnic backgrounds all raise the risk of CKD.** CKD does not strike at random — several factors raise a person's risk and identify who benefits most from testing. The biggest are diabetes and high blood pressure, which together cause most CKD. Other important risk factors include cardiovascular (heart) disease, a family history of kidney failure, older age, obesity, and a history of acute kidney injury. Risk is also higher in several populations, including Black/African American, Hispanic/Latino, Native American, and Asian American people, reflecting a mix of higher rates of diabetes and hypertension and other factors. Smoking and frequent use of NSAID pain relievers add risk too. Because early CKD is silent, people with these risk factors are the ones for whom simple blood (eGFR) and urine (ACR) testing is especially worthwhile, since catching CKD early opens the door to treatments that slow it. Risk factors describe probability across populations, not certainty for any one person. > **Note:** Risk factors describe populations, not individuals — having them does not mean CKD is certain, and lacking them does not rule it out. **Sources:** - [Chronic Kidney Disease (CKD) — risk factors](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd) — NIH / NIDDK - [Chronic Kidney Disease Basics](https://www.cdc.gov/kidney-disease/about/index.html) — CDC --- ## Diagnosis & Testing How CKD is detected and confirmed — the blood eGFR test (creatinine, race-free equations, cystatin C), the urine albumin (ACR) test, confirming the problem is chronic, and when imaging or a biopsy is used. ### The blood test: creatinine and eGFR **A simple blood test measures creatinine, a waste product, and uses it (with age and sex) to estimate the glomerular filtration rate (eGFR) — the main number for kidney function.** The cornerstone blood test for kidney function measures creatinine, a waste product from normal muscle metabolism that healthy kidneys clear from the blood. Because creatinine alone varies with body size and muscle mass, laboratories use it in an equation along with age and sex to calculate the estimated glomerular filtration rate (eGFR), which approximates how many milliliters of blood the kidneys filter each minute. A normal eGFR is roughly 90 or above; a value persistently below 60 suggests reduced kidney function and, if it lasts three months or more, points to CKD. A single low eGFR is not enough to diagnose CKD — temporary factors like dehydration can lower it — so it is repeated to confirm the finding is chronic. The eGFR is also used to stage CKD, guide medication dosing, and time referrals and planning, which makes it one of the most useful single numbers in kidney care. **Sources:** - [Chronic Kidney Disease Tests & Diagnosis](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/tests-diagnosis) — NIH / NIDDK - [Estimated GFR (eGFR)](https://www.kidney.org/kidney-topics/estimated-glomerular-filtration-rate-egfr) — National Kidney Foundation ### The urine test: albumin-to-creatinine ratio (ACR) **A urine test checks for albumin, a protein that leaks through damaged kidney filters; the albumin-to-creatinine ratio (ACR) is an early, sensitive sign of kidney damage.** The second essential CKD test looks at the urine for albumin, a blood protein that healthy kidneys keep out of the urine. When the kidney's filters are damaged, albumin starts to leak through, so finding it in the urine is one of the earliest signs of kidney disease — often appearing before the eGFR drops. The result is reported as the urine albumin-to-creatinine ratio (ACR), which adjusts for how concentrated the urine sample is. An ACR under 30 mg/g is considered normal to mildly increased, 30–300 is moderately increased, and above 300 is severely increased. Because a single sample can be affected by exercise, fever, infection, or other temporary factors, an abnormal ACR is typically confirmed with repeat testing. The ACR is valuable not only for diagnosing CKD but also for predicting how fast it may progress and for tracking whether treatment is reducing the leakage, which is itself a kidney-protective goal. **Sources:** - [Albuminuria: Albumin in the Urine](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/tests-diagnosis/albuminuria-albumin-urine) — NIH / NIDDK - [ACR (Albumin-to-Creatinine Ratio)](https://www.kidney.org/kidney-topics/urine-albumin-creatinine-ratio-uacr) — National Kidney Foundation ### Newer eGFR equations: race-free and cystatin C **U.S. labs have moved to a race-free eGFR equation, and a second blood marker called cystatin C can refine the estimate when a more accurate number is needed.** How eGFR is calculated has evolved. Older creatinine-based equations included a race coefficient that adjusted results for Black patients; recognizing that race is a social rather than biological variable and that the adjustment could delay care, U.S. professional organizations recommended in 2021 moving to a new race-free creatinine equation (CKD-EPI 2021), which laboratories have broadly adopted. In addition, a different blood marker called cystatin C can be measured and combined with creatinine to produce a more accurate eGFR; this is especially useful when the creatinine-based estimate may be misleading — for example in people with unusually high or low muscle mass — or when confirming a borderline result before making important decisions. These refinements aim to make the eGFR fairer and more accurate across diverse patients. The specifics of which equation and markers to use are handled by the laboratory and care team. **Sources:** - [Try the New eGFR Calculator (race-free 2021 equation)](https://www.kidney.org/news-stories/what-new-egfr-calculation-means-your-kidney-disease-diagnosis-and-treatment) — National Kidney Foundation - [eGFR Calculator (CKD-EPI 2021, creatinine and cystatin C)](https://www.kidney.org/professionals/gfr_calculator) — National Kidney Foundation ### Confirming the problem is chronic, not acute **CKD requires the abnormality to persist for at least three months; a single bad result may be temporary acute kidney injury, so tests are repeated before diagnosing CKD.** A key step in diagnosing CKD is establishing that the kidney problem is chronic — lasting at least three months — rather than a sudden, potentially reversible drop called acute kidney injury (AKI). A single abnormal eGFR or ACR can have temporary causes: dehydration, a urinary infection, certain medications, contrast dye, or a passing illness can all transiently worsen the numbers. For that reason, an abnormal result is repeated over time, and a diagnosis of CKD is made when reduced filtering or kidney-damage markers are confirmed to persist. Distinguishing AKI from CKD matters because their causes, urgency, and treatment differ: AKI often needs prompt attention to a specific trigger and may recover, while CKD is managed over the long term to slow progression. People who have had an episode of AKI are also at higher future risk of CKD and benefit from follow-up testing. This is why kidney results are interpreted as a trend, not a single snapshot. **Sources:** - [Chronic Kidney Disease Tests & Diagnosis](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/tests-diagnosis) — NIH / NIDDK - [Acute Kidney Injury (AKI)](https://www.kidney.org/kidney-topics/acute-kidney-injury-aki) — National Kidney Foundation ### Imaging and kidney biopsy **Ultrasound and other imaging can show kidney size, blockages, or cysts; a kidney biopsy is sometimes needed to identify the exact cause when blood tests are not enough.** While blood and urine tests detect and stage CKD, imaging and biopsy help identify its cause when that is unclear or when a specific treatable disease is suspected. Ultrasound is the most common first imaging test — it is painless and radiation-free and can reveal the kidneys' size and shape, obstruction or blockage to urine flow, kidney stones, and cysts such as those of polycystic kidney disease. Other imaging (CT or MRI) may be used in particular situations, with care taken about contrast dye in people with reduced kidney function. When the cause remains uncertain or a glomerular or immune kidney disease is suspected — often signaled by significant protein or blood in the urine — a kidney biopsy may be performed, in which a tiny sample of kidney tissue is taken with a needle and examined under a microscope to pinpoint the disease and guide treatment. The decision to biopsy weighs the value of a precise diagnosis against the small risks of the procedure and is made by the nephrology team. **Sources:** - [Kidney Biopsy — Procedure, Side Effects, Recovery](https://www.kidney.org/kidney-topics/kidney-biopsy) — National Kidney Foundation - [Tests for Kidney Disease (imaging and biopsy)](https://www.kidneyfund.org/all-about-kidneys/tests-kidney-disease) — American Kidney Fund --- ## Acute Emergencies & Red Flags When kidney disease needs urgent or emergency care — dangerously high potassium (hyperkalemia), fluid overload and pulmonary edema, severe uremic symptoms, sudden kidney-function drops (AKI), and dialysis-access problems. Educational; seek medical help promptly for these. ### When kidney disease becomes an emergency **Most CKD is managed calmly over time, but certain situations — chest pain, severe breathlessness, confusion, an irregular heartbeat, or near-absent urine — need urgent care now, not at the next appointment.** Chronic kidney disease is usually a slow, manageable condition, but because the kidneys control fluid, minerals, and waste, certain acute problems can become genuine emergencies. The general rule is that anything affecting breathing, the heart, or consciousness deserves urgent evaluation: severe shortness of breath, chest pain, fainting, a markedly irregular or slow heartbeat, new confusion, seizures, or producing very little or no urine all warrant emergency care (call emergency services or go to an emergency department). Less dramatic but still important warning signs — rapidly worsening swelling, persistent vomiting, an inability to keep fluids down, or feeling profoundly unwell — should prompt prompt contact with the care team. People with advanced CKD or on dialysis are at higher risk for these events, and knowing the red flags in advance helps avoid dangerous delays. The entries below describe the specific emergencies; none of this replaces an in-person assessment, and when in doubt about an urgent symptom, it is safer to seek help. > **Note:** This is educational, not a triage tool. For chest pain, severe breathlessness, fainting, confusion, or a very irregular heartbeat, seek emergency care immediately. **Sources:** - [Recognizing Kidney Disease Symptoms: Warning Signs](https://www.kidney.org/kidney-topics/signs-and-symptoms-kidney-disease) — National Kidney Foundation - [Managing Chronic Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/managing) — NIH / NIDDK ### Dangerously high potassium (hyperkalemia) _(Established)_ **Damaged kidneys can let potassium build up in the blood; severe hyperkalemia can cause life-threatening heart rhythm problems and is a medical emergency, even though it often causes no symptoms until late.** Potassium is a mineral that keeps the heart and muscles working, and the kidneys are the body's main route for removing excess. In CKD — especially advanced CKD, and sometimes worsened by certain medicines or a high-potassium diet — potassium can rise to dangerous levels, a condition called hyperkalemia. What makes it especially dangerous is that it often causes no symptoms until potassium is very high, when it can trigger muscle weakness, numbness or tingling, nausea, and most seriously a slow, irregular, or stopped heartbeat. Sudden or severe hyperkalemia is life-threatening and needs emergency treatment, which is why people with CKD have their potassium monitored with blood tests and may be advised about potassium in their diet and medications. Warning signs that warrant urgent care include muscle weakness that is severe or spreading, palpitations or a very irregular or slow pulse, and shortness of breath. Treatment of hyperkalemia, and any changes to potassium in diet or medicines, must be directed by the care team. > **Note:** Severe hyperkalemia is a medical emergency. Weakness, palpitations, an irregular or slow heartbeat, or breathlessness in someone with kidney disease needs urgent care. **Sources:** - [High Potassium (Hyperkalemia): Causes, Symptoms, and Treatment](https://www.kidney.org/kidney-topics/hyperkalemia-high-potassium) — National Kidney Foundation - [High Potassium (Hyperkalemia): Causes, Prevention and Treatment](https://www.kidneyfund.org/living-kidney-disease/health-problems-caused-kidney-disease/high-potassium-hyperkalemia-causes-prevention-and-treatment) — American Kidney Fund ### Fluid overload and pulmonary edema _(Established)_ **Failing kidneys may not remove enough fluid, which can flood the lungs (pulmonary edema) and cause severe breathlessness — an emergency, especially in advanced CKD or between dialysis sessions.** When the kidneys cannot remove enough salt and water, fluid builds up in the body — first often as swelling in the legs, ankles, or face, and as high blood pressure, but in more severe cases backing up into the lungs. This 'pulmonary edema' causes shortness of breath that can become severe, especially when lying flat or at night, sometimes with a cough, frothy sputum, or a feeling of suffocating, and it is a medical emergency requiring immediate care. Fluid overload is a particular risk in advanced CKD and for people on dialysis who gain too much fluid between sessions, which is why fluid and salt limits and tracking weight are emphasized in their care. Warning signs to act on include rapidly worsening swelling, sudden weight gain, and especially worsening breathlessness or difficulty breathing lying down. Severe breathing difficulty warrants emergency services; lesser but worsening swelling or breathlessness warrants prompt contact with the care team, who manage fluid removal through medication or dialysis. > **Note:** Severe or rapidly worsening breathlessness — especially when lying down — can signal fluid in the lungs and needs emergency care. **Sources:** - [Fluid Overload in a Dialysis Patient](https://www.kidney.org/kidney-topics/fluid-overload-dialysis-patient) — National Kidney Foundation - [Pulmonary edema — symptoms and causes](https://www.mayoclinic.org/diseases-conditions/pulmonary-edema/symptoms-causes/syc-20377009) — Mayo Clinic ### Severe uremia (uremic emergencies) **When kidney failure lets waste products build up to high levels, 'uremia' can cause severe nausea, confusion, and in extreme cases seizures, pericarditis, or coma — signaling that urgent treatment, often dialysis, is needed.** Uremia refers to the buildup of waste products in the blood when the kidneys fail, and while milder symptoms (fatigue, poor appetite, nausea, itching, trouble concentrating) develop gradually, severe uremia is a serious situation. As toxins accumulate, a person may develop persistent vomiting, marked confusion or drowsiness, hiccups, and in extreme, untreated cases seizures, inflammation of the sac around the heart (uremic pericarditis), bleeding tendencies, or coma. These severe uremic symptoms are warning signs that kidney function has fallen critically low and that urgent treatment — frequently the initiation of dialysis — is needed, and they are part of how clinicians decide when dialysis must begin. New or worsening confusion, persistent vomiting with inability to keep fluids down, or chest pain in someone with advanced kidney disease should prompt urgent medical assessment. People approaching kidney failure are monitored closely precisely so that treatment can start before uremia becomes dangerous. > **Note:** New confusion, persistent vomiting, or chest pain in advanced kidney disease needs urgent medical assessment — these can signal severe uremia. **Sources:** - [Kidney Failure (ESRD) — Symptoms, Stages & Treatment](https://www.kidney.org/kidney-topics/kidney-failure) — National Kidney Foundation - [Choosing a Treatment for Kidney Failure](https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/choosing-treatment) — NIH / NIDDK ### Sudden drops in kidney function (acute kidney injury) **On top of CKD, kidney function can drop suddenly — from dehydration, infection, certain medicines, or contrast dye — sometimes producing little urine; this 'acute-on-chronic' injury needs prompt evaluation.** People with chronic kidney disease are more vulnerable to acute kidney injury (AKI), a sudden worsening of kidney function over hours to days, sometimes called 'acute-on-chronic' kidney injury. Common triggers include dehydration (from vomiting, diarrhea, or poor fluid intake, often during illness), serious infections, low blood pressure, certain medications (such as NSAID pain relievers and some others), and iodinated contrast dye used in some scans. Signs can include producing much less urine than usual, rapidly worsening swelling, increasing fatigue or confusion, and nausea — though sometimes it is detected only on blood tests. AKI is a medical situation that needs prompt evaluation because the cause may be reversible if addressed quickly, and because it can tip advanced CKD toward needing urgent dialysis. During illnesses that cause dehydration, people with CKD are often advised about 'sick-day' guidance, including which medicines may need to be paused — but those decisions belong with the clinician or pharmacist, not guesswork. > **Note:** Producing very little urine, or rapidly worsening swelling, confusion, or nausea, can signal acute kidney injury and needs prompt medical attention. **Sources:** - [Acute Kidney Injury (AKI)](https://www.kidney.org/kidney-topics/acute-kidney-injury-aki) — National Kidney Foundation - [Acute Kidney Injury (AKI) — about](https://www.niddk.nih.gov/health-information/kidney-disease) — NIH / NIDDK ### Dialysis access emergencies **For people on hemodialysis, problems with the access (fistula, graft, or catheter) — heavy bleeding, signs of infection, or a clotted access — are urgent and can be dangerous.** People on hemodialysis rely on a vascular access — usually a surgically created fistula or graft in the arm, or a central venous catheter — and problems with it are among the urgent situations specific to dialysis. Heavy or persistent bleeding from an access site is an emergency: firm pressure should be applied and emergency help sought, because blood loss can be rapid. Signs of infection — redness, warmth, swelling, pus, or fever, especially around a catheter — also need prompt attention, since access infections can spread to the bloodstream and become life-threatening. A loss of the normal 'thrill' (the buzzing vibration felt over a fistula or graft) can mean the access has clotted and needs urgent evaluation to save it. Dialysis units teach people how to care for and check their access daily for exactly these reasons. Any of these access problems should be reported to the dialysis unit or, when severe (heavy bleeding, high fever, feeling very unwell), treated as an emergency. > **Note:** Heavy bleeding from a dialysis access is an emergency — apply firm pressure and get help. Fever or redness around an access, or a lost 'thrill,' needs urgent contact with the dialysis unit. **Sources:** - [Hemodialysis Access (vascular access)](https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/hemodialysis) — NIH / NIDDK - [Hemodialysis](https://www.kidney.org/kidney-topics/hemodialysis) — National Kidney Foundation --- ## Treatments & Medications How CKD progression is slowed — controlling the cause and blood pressure, and the modern kidney-protective medicines (ACE inhibitors/ARBs, SGLT2 inhibitors, finerenone, and GLP-1 receptor agonists). Educational; the regimen and any changes belong with the care team. ### The goals: slow progression and protect the heart **CKD treatment aims to slow the loss of kidney function and reduce cardiovascular risk by controlling the cause, lowering blood pressure, reducing albuminuria, and using kidney-protective medicines.** There is no cure that restores damaged kidneys, so CKD treatment focuses on two linked goals: slowing the decline of kidney function and lowering the high risk of heart attack, stroke, and heart failure that accompanies CKD. The strategy combines treating the underlying cause (most often diabetes and high blood pressure), controlling blood pressure to target, reducing albuminuria (the protein leak that both signals and drives damage), and using medicines now proven to protect the kidneys. A major shift in recent years is that several of these medicines protect the heart as well as the kidney, so modern care often layers them as a set of complementary 'pillars.' Lifestyle measures, careful attention to avoiding kidney injury, and management of complications (anemia, bone-mineral problems, high potassium) round out the plan. Treatment is highly individualized — depending on the cause, stage, other conditions, and the person's preferences — and every medicine and dose decision belongs with the care team. **Sources:** - [Managing Chronic Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/managing) — NIH / NIDDK - [Medicines with Kidney-Protective Factors](https://www.kidney.org/subject/medicines-kidney-protective-factors) — National Kidney Foundation ### ACE inhibitors and ARBs _(Established)_ **ACE inhibitors and ARBs lower blood pressure and reduce protein in the urine, protecting the kidneys beyond their pressure-lowering effect — a cornerstone of CKD treatment, especially with albuminuria.** ACE inhibitors (such as lisinopril) and ARBs (such as losartan) are blood-pressure medicines that have a special role in kidney disease: by relaxing the blood vessels and reducing pressure within the kidney's filters, they lower the amount of albumin leaking into the urine and slow the progression of CKD beyond what their blood-pressure effect alone would predict. For this reason they are a cornerstone of treatment for people with CKD and albuminuria, particularly in diabetic kidney disease, and they protect the heart as well. A few practical points are managed by the care team: starting or increasing the dose can cause a small, expected rise in creatinine and a rise in potassium, so blood tests are checked after changes; the two classes are generally not combined; and these drugs are usually paused during illnesses with dehydration and avoided in pregnancy. They are typically titrated to the highest tolerated dose. Because of the potassium and kidney-function monitoring involved, dosing and adjustments are always the prescriber's decision. **Sources:** - [ACE Inhibitors and ARBs](https://www.kidney.org/kidney-topics/ace-inhibitors-and-arbs) — National Kidney Foundation - [High Blood Pressure & Kidney Disease (medicines)](https://www.niddk.nih.gov/health-information/kidney-disease/high-blood-pressure) — NIH / NIDDK ### SGLT2 inhibitors _(Established)_ **SGLT2 inhibitors, first developed for diabetes, are now proven to slow CKD progression and reduce heart failure and death — even in people without diabetes — and are a major advance in kidney care.** SGLT2 inhibitors (such as dapagliflozin and empagliflozin) were first used to lower blood sugar in type 2 diabetes by making the kidneys excrete glucose in the urine, but large trials revealed a powerful additional benefit: they substantially slow the progression of chronic kidney disease and reduce hospitalizations for heart failure and cardiovascular death. In 2021 dapagliflozin became the first SGLT2 inhibitor approved by the FDA for CKD in people at risk of progression with or without type 2 diabetes — a landmark, since it extended the benefit to non-diabetic kidney disease. These medicines are now recommended for many people with CKD and albuminuria, often added on top of an ACE inhibitor or ARB, and can be used down to fairly low levels of kidney function. Side effects to be aware of include genital yeast infections and, rarely, a serious condition called ketoacidosis, and they are typically paused during acute illness and around surgery. As always, whether and how to use them is decided by the care team. **Sources:** - [FARXIGA approved in the US for the treatment of chronic kidney disease](https://www.astrazeneca.com/media-centre/press-releases/2021/farxiga-approved-in-the-us-for-ckd.html) — AstraZeneca, 2021 - [New Medications for Type 2 Diabetes and Kidney Disease: SGLT2 Inhibitors, Finerenone, and GLP-1 RA](https://www.kidney.org/news-stories/game-changing-medications-kidney-disease-and-type-2-diabetes) — National Kidney Foundation ### Finerenone (a nonsteroidal MRA) _(Established)_ **Finerenone is a newer kidney-protective medicine for CKD with type 2 diabetes that lowers albuminuria and reduces kidney and heart complications; it requires potassium monitoring.** Finerenone (brand name Kerendia) is a nonsteroidal mineralocorticoid receptor antagonist (MRA), a newer class of medicine that targets a hormone pathway driving inflammation and scarring in the kidney and heart. In large trials (FIDELIO-DKD and FIGARO-DKD) in people with chronic kidney disease associated with type 2 diabetes, finerenone reduced albuminuria and lowered the risk of CKD progression, kidney failure, cardiovascular death, non-fatal heart attack, and heart-failure hospitalization, and on that basis the FDA approved it in 2021. It is often used alongside an ACE inhibitor or ARB and an SGLT2 inhibitor as part of a layered, kidney-and-heart-protective approach. Because it can raise blood potassium, potassium levels are checked before starting and during treatment, and it has certain drug interactions, so its use is carefully managed. Whether finerenone is appropriate, and all monitoring and dosing, are decisions for the care team. > **Note:** Finerenone can raise blood potassium and has drug interactions; potassium monitoring and all dosing decisions belong with the prescriber. **Sources:** - [FDA Approves Drug to Reduce Risk of Serious Kidney and Heart Complications in CKD with Type 2 Diabetes](https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-drug-reduce-risk-serious-kidney-and-heart-complications-adults-chronic-kidney-disease) — U.S. Food and Drug Administration, 2021 - [New Medications for Type 2 Diabetes and Kidney Disease (finerenone)](https://www.kidney.org/news-stories/game-changing-medications-kidney-disease-and-type-2-diabetes) — National Kidney Foundation ### GLP-1 receptor agonists _(Emerging)_ **GLP-1 receptor agonists, used for diabetes and weight, have shown kidney and cardiovascular benefits and are an emerging part of the CKD treatment story for people with type 2 diabetes.** GLP-1 receptor agonists (such as semaglutide and dulaglutide) are injectable (and, for some, oral) medicines used for type 2 diabetes and weight management, and they have become part of the kidney-protective picture. A large trial of semaglutide in people with type 2 diabetes and chronic kidney disease (FLOW) found it reduced the risk of major kidney events and kidney-related and cardiovascular death, adding to earlier evidence that this class lowers cardiovascular risk and albuminuria. As a result, GLP-1 receptor agonists are increasingly considered for people with CKD and type 2 diabetes, especially where there is also a need to improve glucose control, reduce weight, or lower cardiovascular risk, often alongside SGLT2 inhibitors and the other pillars. Common side effects are gastrointestinal (nausea, especially early on). Their role in CKD continues to expand, and whether they fit a given person's plan — and at what dose — is determined by the care team. **Sources:** - [New Medications for Type 2 Diabetes and Kidney Disease: SGLT2 Inhibitors, Finerenone, and GLP-1 RA](https://www.kidney.org/news-stories/game-changing-medications-kidney-disease-and-type-2-diabetes) — National Kidney Foundation - [Semaglutide and Kidney Outcomes in Type 2 Diabetes and CKD (FLOW trial)](https://www.nejm.org/doi/full/10.1056/NEJMoa2403347) — New England Journal of Medicine, 2024 ### Blood pressure control and treating the cause _(Established)_ **Lowering blood pressure to an individualized target and tightly managing the underlying cause — especially diabetes — are foundational to slowing CKD, on top of the kidney-protective medicines.** Underneath the newer medicines, two foundations remain central to CKD care. The first is blood-pressure control: because high blood pressure both causes and accelerates kidney damage, getting it to an individualized target (often lower than for people without CKD, especially with albuminuria) is one of the most effective ways to slow decline and protect the heart and brain. This usually combines lifestyle measures with medication, frequently built around an ACE inhibitor or ARB. The second is treating the underlying cause — most importantly managing blood glucose in diabetes, but also addressing glomerular diseases, relieving obstruction, or treating other specific causes when present. Controlling cholesterol (commonly with a statin) and stopping smoking further reduce the cardiovascular risk that is the leading threat to people with CKD. These foundations work together with the kidney-protective drug 'pillars,' and the exact targets and medicines are tailored by the care team to each person's overall situation. **Sources:** - [Managing Chronic Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/managing) — NIH / NIDDK - [High Blood Pressure and Chronic Kidney Disease](https://www.kidney.org/high-blood-pressure-and-chronic-kidney-disease) — National Kidney Foundation --- ## Dialysis & Transplant Kidney replacement therapy for kidney failure — how hemodialysis and peritoneal dialysis work, kidney transplant (living and deceased donor), conservative non-dialysis care, and why planning ahead matters. ### When the kidneys fail: the treatment options **When CKD reaches kidney failure, the main options are hemodialysis, peritoneal dialysis, a kidney transplant, or — for some — conservative care focused on comfort; the choice is personal and planned in advance.** When chronic kidney disease progresses to kidney failure (end-stage kidney disease), the kidneys can no longer keep a person well on their own, and a decision about kidney replacement therapy becomes necessary. There are several paths: hemodialysis (filtering the blood through a machine), peritoneal dialysis (using the lining of the abdomen to filter), and kidney transplantation (receiving a healthy donor kidney). For some people — particularly older adults with other serious illnesses — a fourth option, conservative or supportive (non-dialysis) management focused on symptoms and quality of life, is a valid and deliberate choice. None of these is automatically 'best'; the right path depends on a person's health, lifestyle, values, and preferences, and many people are candidates for more than one. Because preparing for any of them takes time (creating dialysis access, evaluating for transplant), these conversations ideally happen well before kidney failure arrives, so that the transition is planned rather than rushed. Education and support from the kidney care team are central to making an informed choice. **Sources:** - [Choosing a Treatment for Kidney Failure](https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/choosing-treatment) — NIH / NIDDK - [Choosing a Treatment for Kidney Failure](https://www.kidney.org/kidney-topics/choosing-treatment-kidney-failure) — National Kidney Foundation ### Hemodialysis **Hemodialysis filters the blood through a machine and artificial kidney, usually about three times a week in a center or at home, and needs a vascular access prepared in advance.** Hemodialysis cleans the blood outside the body: blood is pumped through a machine and a filter (a dialyzer, or 'artificial kidney') that removes waste products and extra fluid, then returned to the body. It is most commonly done at a dialysis center about three times a week, with each session typically lasting around four hours, though home hemodialysis — sometimes more frequent or done overnight — is an option for suitable people and can offer more flexibility. Hemodialysis requires a reliable vascular access, ideally an arteriovenous fistula (a surgically joined artery and vein in the arm) created weeks to months ahead so it can mature, because a fistula generally works best and has fewer complications than a graft or a catheter. Between sessions, fluid and certain minerals build up, so people on hemodialysis follow fluid and dietary guidance and track their weight. It is an effective, life-sustaining treatment, and the schedule and approach are tailored with the dialysis team. **Sources:** - [Hemodialysis](https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/hemodialysis) — NIH / NIDDK - [Hemodialysis](https://www.kidney.org/kidney-topics/hemodialysis) — National Kidney Foundation ### Peritoneal dialysis **Peritoneal dialysis uses the lining of the abdomen as a natural filter, with cleansing fluid exchanged through a catheter; it is usually done at home, daily, by the person themselves.** Peritoneal dialysis (PD) uses the body's own peritoneum — the membrane lining the abdomen — as a filter. A soft catheter is placed in the abdomen, and a sterile cleansing fluid (dialysate) is run in, left to dwell while waste and extra fluid pass into it across the membrane, then drained out and replaced — a cycle called an exchange. PD is usually done at home and managed by the person or a caregiver, in one of two main forms: continuous ambulatory PD, with several manual exchanges spread through the day, or automated PD, in which a machine performs exchanges overnight while the person sleeps. Its advantages include independence, a flexible schedule, and avoiding needles for blood access; its considerations include the daily routine, the need for a clean technique to avoid peritonitis (infection of the abdominal lining), and keeping supplies at home. PD and hemodialysis are broadly comparable in effectiveness for many people, so the choice often comes down to lifestyle and medical factors decided with the care team. **Sources:** - [Peritoneal Dialysis](https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/peritoneal-dialysis) — NIH / NIDDK - [Peritoneal Dialysis: CAPD and APD](https://www.kidney.org/kidney-topics/peritoneal-dialysis) — National Kidney Foundation ### Kidney transplant **A transplant places a healthy donor kidney into the body and often offers the best quality and length of life for suitable people, but it is a treatment — not a cure — and requires lifelong anti-rejection medicine.** A kidney transplant is an operation that places a healthy kidney from a donor into a person with kidney failure; the new kidney takes over the work of filtering, often allowing a fuller, more flexible life than dialysis and, for suitable candidates, better long-term survival. Donor kidneys come either from a living donor (often a relative or friend, but also non-directed donors) or from a deceased donor, and a single donated kidney is enough to do the job. Importantly, a transplant is a treatment, not a cure: the recipient still has chronic kidney disease, must take immunosuppressant (anti-rejection) medicines for as long as the kidney works to prevent the immune system from attacking it, and these medicines carry their own risks (such as higher infection and certain cancer risks). Not everyone is a candidate, evaluation is thorough, and waiting times for a deceased-donor kidney can be long, which is why a 'pre-emptive' transplant before starting dialysis — when possible, often via a living donor — is encouraged. The transplant team guides every step. **Sources:** - [Kidney Transplant](https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/kidney-transplant) — NIH / NIDDK - [Kidney Transplant](https://www.kidney.org/kidney-topics/kidney-transplant) — National Kidney Foundation ### Conservative (non-dialysis) management **For some people — often older adults with other serious illnesses — choosing not to start dialysis and instead focusing on symptoms and quality of life is a valid, deliberate option.** Dialysis is life-sustaining, but it is not the right choice for everyone, and conservative management (also called supportive or non-dialysis care, or active medical management without dialysis) is a recognized, deliberate option. It focuses on controlling symptoms — such as nausea, itching, breathlessness, and fluid buildup — with medicines and diet, slowing decline where possible, and prioritizing quality of life and comfort, often with input from palliative care. This path is considered most often for older adults or people with multiple serious illnesses or frailty, for whom dialysis might add burden (frequent treatments, hospitalizations) without necessarily adding good-quality time, and studies suggest the survival difference can be small in such groups. Choosing conservative care is a personal, value-driven decision made together with the care team and family, and it is not 'giving up' — it is a different, legitimate way of managing kidney failure centered on what matters most to the individual. People can also revisit the decision as circumstances change. **Sources:** - [Choosing a Treatment for Kidney Failure (conservative management)](https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/choosing-treatment) — NIH / NIDDK - [Kidney Failure (ESRD) — treatment choices including conservative care](https://www.kidney.org/kidney-topics/kidney-failure) — National Kidney Foundation ### Why planning ahead matters **Preparing for kidney failure early — choosing a path, creating dialysis access, or pursuing a pre-emptive transplant — leads to smoother, safer transitions and better outcomes than starting in a crisis.** One of the most consequential lessons in advanced CKD is that preparation matters. A hemodialysis fistula needs to be created weeks to months before it is used so it can mature; a peritoneal dialysis catheter needs placing and healing time; and transplant evaluation and finding a living donor take time as well. People who reach kidney failure without a plan often have to start hemodialysis urgently through a temporary catheter, which carries higher risks of infection and complications than a planned start with a mature fistula or a pre-emptive transplant. For this reason, nephrology teams begin these conversations and preparations well before kidney failure — commonly when CKD is advanced but not yet at the failure stage — covering education on the options, evaluation for transplant, and creating access for the chosen modality. Planning also lets a person choose the path that best fits their life rather than defaulting into whatever is fastest in a crisis. The timing of preparation is guided by the care team based on how the kidney function is trending. **Sources:** - [Kidney Failure (ESRD) — Symptoms, Stages & Treatment](https://www.kidney.org/kidney-topics/kidney-failure) — National Kidney Foundation - [Hemodialysis Access (planning vascular access)](https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/hemodialysis) — NIH / NIDDK --- ## Nutrition & the CKD Diet Kidney-friendly eating that shifts as CKD advances — managing sodium, potassium, phosphorus, protein, and fluid — and the central role of a renal dietitian. Educational; specific targets are individualized by the care team. ### Why diet matters and how it changes by stage **Diet is a powerful tool in CKD because the kidneys handle what we eat and drink; early on the focus is heart-healthy eating, with more specific limits on minerals and protein as CKD advances.** Because the kidneys process much of what we eat and drink — removing waste, balancing minerals, and handling fluid — diet is one of the most important tools for living well with CKD and easing the kidneys' workload. In the early stages (1 and 2), the emphasis is usually on a generally heart-healthy diet: lower salt, plenty of vegetables and fruit, less processed food, and good blood-pressure and blood-sugar control, without many specific restrictions. As CKD advances (stages 3 to 5), the kidneys handle certain nutrients less well, so eating plans often become more tailored — managing sodium, potassium, phosphorus, protein, and sometimes fluid to specific targets. Crucially, these targets are individualized: the right amount of potassium or protein for one person can be wrong for another, and over-restricting can cause malnutrition. That is why CKD nutrition is best guided by a kidney dietitian working with the care team, using a person's lab results and overall health, rather than generic internet 'kidney diets.' > **Note:** Dietary targets in CKD are individualized — do not self-impose strict limits. Over-restricting can cause malnutrition; work with a kidney dietitian. **Sources:** - [Healthy Eating for Adults with Chronic Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/healthy-eating-adults-chronic-kidney-disease) — NIH / NIDDK - [Kidney-Friendly Eating Plan](https://www.kidneyfund.org/living-kidney-disease/healthy-eating-activity/kidney-friendly-eating-plan) — American Kidney Fund ### Sodium (salt) **Limiting sodium helps control blood pressure and fluid buildup, which protects the kidneys and heart; most of the salt we eat comes from processed and restaurant foods, not the shaker.** Sodium, the main part of salt, drives up blood pressure and causes the body to hold onto fluid — both of which strain the kidneys and the heart — so reducing sodium is one of the most broadly recommended steps in CKD, often with a target of under about 2,300 mg per day (and sometimes lower, as advised). A key insight is that most dietary sodium does not come from the salt shaker but from packaged, processed, canned, and restaurant foods — deli meats, canned soups, snack foods, sauces, and fast food. Practical, dietitian-endorsed strategies include cooking more at home, choosing fresh or frozen over canned, rinsing canned foods, reading Nutrition Facts labels for sodium, and flavoring food with herbs and spices instead of salt. A caution: many 'salt substitutes' are high in potassium, which can be dangerous in CKD, so they should not be used without checking with the care team. Lowering sodium supports the blood-pressure control that is central to slowing CKD. > **Note:** Many salt substitutes are high in potassium, which can be hazardous in CKD — check with the care team before using them. **Sources:** - [Healthy Eating for Adults with Chronic Kidney Disease (sodium)](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/healthy-eating-adults-chronic-kidney-disease) — NIH / NIDDK - [Sodium and Your CKD Diet](https://www.kidney.org/kidney-topics/sodium-and-your-ckd-diet-how-to-spice-your-cooking) — National Kidney Foundation ### Potassium **As CKD advances, the kidneys may not remove potassium well, so blood levels can rise dangerously; some people need to limit high-potassium foods, but the right amount is individualized.** Potassium is essential for nerves and muscles, including the heartbeat, and is normally balanced by the kidneys. In more advanced CKD, the kidneys may not clear potassium effectively, allowing blood levels to climb — and high potassium (hyperkalemia) can cause dangerous heart-rhythm problems, often with no warning symptoms. For people whose blood potassium runs high, the care team may advise limiting high-potassium foods (such as bananas, oranges, potatoes, tomatoes, and many beans), choosing lower-potassium alternatives, and using cooking techniques that reduce potassium in some vegetables. Importantly, this is not a blanket rule for everyone with CKD: many people, especially in earlier stages, do not need to restrict potassium, and unnecessary restriction means missing out on healthy produce. Certain medicines (including some used to protect the kidneys) and salt substitutes can also raise potassium. Because the right potassium target depends on blood levels, medicines, and stage, it should be set with a dietitian and clinician, guided by regular blood tests — not self-imposed. > **Note:** Potassium limits are individualized and based on blood tests — not everyone with CKD needs to restrict it. High potassium can be dangerous; manage it with the care team. **Sources:** - [Potassium in Your CKD Diet](https://www.kidney.org/kidney-topics/potassium-your-ckd-diet) — National Kidney Foundation - [Healthy Eating for Adults with Chronic Kidney Disease (potassium)](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/healthy-eating-adults-chronic-kidney-disease) — NIH / NIDDK ### Phosphorus **Damaged kidneys remove phosphorus less well, and high levels harm bones and blood vessels; limiting added phosphorus — especially in processed foods — is a key part of the advanced-CKD diet.** Phosphorus is a mineral that works with calcium and vitamin D to keep bones healthy, but as CKD advances the kidneys remove it less effectively, so blood phosphorus can rise. Over time, high phosphorus contributes to the bone and blood-vessel problems of CKD–mineral and bone disorder, weakening bones and promoting calcium deposits in arteries. Managing it focuses especially on added (inorganic) phosphorus, which is found in many processed foods, fast foods, colas, and some packaged products and is absorbed very efficiently — checking ingredient labels for additives containing 'PHOS' (such as phosphoric acid and various phosphates) is a practical strategy. Naturally occurring phosphorus in protein foods like dairy, meat, and beans is absorbed less completely, so guidance balances limiting it against maintaining adequate nutrition. Some people also need phosphate-binder medicines taken with meals to reduce how much phosphorus is absorbed. Phosphorus targets, dietary changes, and any binders are managed by the care team and dietitian using blood results. **Sources:** - [Phosphorus and Your CKD Diet](https://www.kidney.org/kidney-topics/phosphorus-and-your-ckd-diet) — National Kidney Foundation - [Healthy Eating for Adults with Chronic Kidney Disease (phosphorus)](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/healthy-eating-adults-chronic-kidney-disease) — NIH / NIDDK ### Protein **Protein needs in CKD are a balancing act — too much can stress the kidneys, but too little risks malnutrition, and needs change markedly once a person starts dialysis.** Protein is essential for muscle, healing, and immune function, but it also produces waste that the kidneys must clear, so protein intake in CKD is a careful balance rather than simply 'less is better.' In CKD before dialysis, very high protein intake can add to the kidneys' workload, and a moderate, often somewhat reduced protein intake may be advised for some people to ease that burden — but cutting protein too far risks malnutrition and muscle loss, which carry their own serious harms. The balance flips with dialysis: dialysis removes protein and increases needs, so people on dialysis are usually advised to eat more protein, not less. Because of these competing concerns and the differences by stage and treatment, protein is an area where individualized guidance from a renal dietitian is especially important, using a person's stage, nutrition status, and labs. The goal is enough good-quality protein to stay nourished without unnecessarily overworking the kidneys — a target only a professional can set well. > **Note:** Protein needs differ a lot by stage and especially with dialysis — do not cut protein on your own, as too little causes malnutrition. A renal dietitian should set the target. **Sources:** - [Nutrition and Kidney Disease, Stages 1–5 (Not on Dialysis)](https://www.kidney.org/kidney-topics/nutrition-and-kidney-disease-stages-1-5-not-dialysis) — National Kidney Foundation - [Eating & Nutrition for Hemodialysis (protein needs)](https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/hemodialysis/eating-nutrition) — NIH / NIDDK ### Fluid management and the renal dietitian **Some people with advanced CKD or on dialysis need to limit fluids to avoid overload; a renal dietitian individualizes the whole plan so it protects the kidneys without causing malnutrition.** Fluid is the final piece of the CKD diet. Many people with earlier CKD do not need to restrict fluids and should stay well hydrated, but those with advanced CKD or kidney failure — especially on dialysis — may need to limit how much they drink, because failing kidneys cannot remove excess fluid, which can cause swelling, high blood pressure, and dangerous fluid in the lungs. Fluid limits are often tied to urine output and tracked using daily weight between dialysis sessions. Because every element of CKD nutrition — sodium, potassium, phosphorus, protein, and fluid — must be balanced against each other and against the risk of malnutrition, and because targets shift with stage, lab results, and treatment, the renal (kidney) dietitian is central to CKD care. They translate the person's numbers and life into a realistic, individualized plan, adjust it over time, and help avoid the twin pitfalls of overload and undernutrition. Anyone with CKD benefits from a referral to a kidney dietitian rather than relying on generic diet advice. **Sources:** - [Eating Right with Kidney Failure (fluids)](https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/eating-right) — NIH / NIDDK - [Fluid Overload in a Dialysis Patient](https://www.kidney.org/kidney-topics/fluid-overload-dialysis-patient) — National Kidney Foundation --- ## Therapies & Lifestyle Non-drug ways to slow CKD and protect the heart — physical activity, not smoking, healthy weight, lifestyle support for blood pressure and glucose, sensible alcohol limits, and avoiding kidney injury. Educational. ### How lifestyle slows kidney disease **Lifestyle changes work largely by controlling the forces that damage kidneys — high blood pressure and blood sugar — and by lowering the cardiovascular risk that is the biggest threat in CKD.** Lifestyle measures are not a sideshow in CKD; they act on the same drivers that medicines target. Because high blood pressure and high blood glucose are the leading causes of kidney damage, anything that helps control them — physical activity, a heart-healthy and lower-sodium diet, a healthy weight, not smoking, and limiting alcohol — directly helps protect the kidneys. Just as importantly, the most common cause of death in people with CKD is cardiovascular disease, so lifestyle changes that protect the heart are protecting life expectancy, not just kidney numbers. These habits also improve energy, mood, and overall wellbeing, which matters for living well with a long-term condition. Lifestyle works best alongside, not instead of, the kidney-protective medicines and regular monitoring, as part of an integrated plan. The specifics — how much exercise, what dietary targets — should be tailored to the individual with the care team, especially in advanced CKD or on dialysis. **Sources:** - [Preventing Chronic Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/prevention) — NIH / NIDDK - [Managing Chronic Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/managing) — NIH / NIDDK ### Physical activity and exercise **Regular physical activity helps control blood pressure, blood sugar, and weight, supports heart health and mood, and is encouraged in CKD — tailored to the person's ability.** Being physically active is one of the most broadly beneficial things a person with CKD can do. Regular activity helps lower blood pressure, improve blood-sugar control, manage weight, strengthen the heart, and lift mood and energy — addressing several of the forces that drive both kidney decline and cardiovascular risk. General guidance encourages most adults to aim for regular moderate activity (such as brisk walking) across the week, plus some strengthening, but the right amount and type depend on the individual, and people with CKD — especially those with heart disease, on dialysis, or who have been inactive — should check with their care team before starting and may benefit from a gradual, supervised approach. Even modest movement helps, and activity can be built up over time. For people on dialysis, some centers support exercise even during treatment. The goal is consistent, sustainable activity matched to ability, which supports both kidney and overall health. **Sources:** - [Exercise and Chronic Kidney Disease](https://www.kidney.org/kidney-topics/exercise-and-chronic-kidney-disease) — National Kidney Foundation - [Managing Chronic Kidney Disease (physical activity)](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/managing) — NIH / NIDDK ### Stopping smoking _(Established)_ **Smoking damages blood vessels throughout the body, speeds the progression of kidney disease, and adds heavily to cardiovascular risk; quitting is one of the most protective steps in CKD.** Smoking is especially harmful in kidney disease. It damages and narrows blood vessels everywhere — including the small vessels that the kidneys depend on — raises blood pressure, and is linked to faster progression of CKD and a higher risk of kidney failure, as well as greatly increasing the risk of the heart attacks and strokes that are the leading cause of death in CKD. Quitting smoking therefore protects both the kidneys and the heart, and the benefits begin soon after stopping and grow over time. Because nicotine is addictive, quitting is hard, but support works: counseling, quitlines, and approved stop-smoking medications substantially improve success, and a care team can help build a plan and choose options that are appropriate for someone with CKD. Avoiding secondhand smoke and vaping is sensible too. For anyone with kidney disease who smokes, stopping is among the highest-impact changes they can make. **Sources:** - [Smoking and Kidney Health](https://www.kidney.org/kidney-topics/smoking-and-kidney-health) — National Kidney Foundation - [Preventing Chronic Kidney Disease (quit smoking)](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/prevention) — NIH / NIDDK ### Healthy weight and heart-healthy eating **Reaching or keeping a healthy weight and following a heart-healthy, lower-sodium eating pattern help control blood pressure, blood sugar, and cholesterol — protecting both kidneys and heart.** Excess weight contributes to high blood pressure, type 2 diabetes, and other drivers of kidney damage, so reaching and maintaining a healthier weight can ease the strain on the kidneys and lower cardiovascular risk. This is achieved through a sustainable combination of eating patterns and activity rather than crash dieting. A heart-healthy diet — rich in vegetables, fruit (within any potassium guidance), whole grains, and lean proteins, and low in sodium, added sugars, and heavily processed foods — supports blood pressure, blood sugar, and cholesterol control all at once, which is exactly what CKD care aims for. As CKD advances, this general healthy-eating pattern is layered with the more specific mineral and protein guidance covered in the nutrition section, ideally with a renal dietitian so the plan stays balanced and avoids malnutrition. Weight and diet changes work best when realistic and gradual, and any significant change in advanced CKD should be coordinated with the care team. **Sources:** - [Preventing Chronic Kidney Disease (healthy weight and diet)](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/prevention) — NIH / NIDDK - [Kidney-Friendly Eating Plan](https://www.kidneyfund.org/living-kidney-disease/healthy-eating-activity/kidney-friendly-eating-plan) — American Kidney Fund ### Alcohol limits and avoiding kidney injury **Keeping alcohol within recommended limits, staying hydrated during illness, and avoiding routine NSAID painkillers help protect the kidneys from added, avoidable damage.** Beyond the big lifestyle levers, some everyday habits directly help protect the kidneys from avoidable harm. Heavy alcohol use raises blood pressure and can harm the kidneys and overall health, so keeping alcohol within generally recommended limits (and discussing what is appropriate, given other conditions and medicines) is sensible. Two practical cautions matter especially: first, frequent or high-dose use of NSAID pain relievers (such as ibuprofen and naproxen) can reduce blood flow to the kidneys and worsen kidney function, so people with CKD are often advised to limit or avoid them and to ask about safer pain-relief options. Second, dehydration — from illness with vomiting or diarrhea, or simply not drinking enough — can acutely worsen kidney function, so staying adequately hydrated and following 'sick-day' guidance is protective. These are educational points: which painkillers are appropriate, and any sick-day medication adjustments, should be confirmed with a clinician or pharmacist rather than guessed. > **Note:** Routine NSAID use can worsen kidney function — ask a clinician or pharmacist about safer pain relief rather than self-treating. **Sources:** - [Pain Medications for CKD: Risks, Safety, and Alternatives](https://www.kidney.org/kidney-topics/pain-medicines-and-kidney-disease) — National Kidney Foundation - [Preventing Chronic Kidney Disease (protecting the kidneys)](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/prevention) — NIH / NIDDK --- ## Patient Care & Self-Management Living day-to-day with CKD — knowing your eGFR and ACR numbers, managing medicines, home blood-pressure monitoring, vaccines and infection prevention, mental health, and building a care team. Educational. ### Knowing and tracking your numbers **Understanding your eGFR, urine albumin (ACR), blood pressure, and (if relevant) blood sugar — and watching their trends over time — helps you and your team manage CKD actively.** Living well with CKD is easier when a person understands and follows their key numbers. The two kidney measures are eGFR (how well the kidneys filter) and urine ACR (how much albumin is leaking), and tracking how these trend over time is often more informative than any single reading — a stable eGFR is reassuring, while a steadily falling one signals active disease that needs attention. Alongside these, blood pressure and, for people with diabetes, blood-sugar control (such as A1c) are central, because they drive both kidney and heart outcomes. Other labs the team watches include potassium, phosphorus, calcium, parathyroid hormone, bicarbonate, and hemoglobin, which reflect the complications of CKD. Many people find it helpful to keep a simple record of their results, ask what each number means and what the target is, and bring questions to appointments. Being an informed partner in care supports better decisions, though interpreting the full picture remains the care team's role. **Sources:** - [Managing Chronic Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/managing) — NIH / NIDDK - [Know Your Kidney Numbers: Two Simple Tests (eGFR and uACR)](https://www.kidney.org/kidney-topics/know-your-kidney-numbers-two-simple-tests) — National Kidney Foundation ### Managing medications safely **CKD often means several medicines plus the need to dose-adjust or avoid some drugs by kidney function; keeping one current medication list and using a pharmacist keeps the regimen safe.** Medication management is a big part of CKD self-care for two reasons: people with CKD often take several medicines (for blood pressure, the kidneys, diabetes, cholesterol, and complications like anemia or bone disease), and many drugs are handled by the kidneys, so doses may need adjusting — or the drug avoided — as kidney function changes. This makes a few habits genuinely protective: keep one up-to-date list of every prescription, over-the-counter product, vitamin, and supplement; show it at every appointment and to the pharmacist with each new medicine; use one pharmacy where possible so interactions and renal dosing are screened; and always mention you have kidney disease (and your latest eGFR if known) when starting anything new, including at a new doctor or before a scan. Taking medicines as prescribed and not stopping or changing doses on your own are important, since several CKD medicines need careful titration and monitoring. The pharmacist is an underused ally for keeping a complex regimen safe. > **Note:** Doses of many medicines depend on kidney function — don't start, stop, or change medicines (including OTC products) on your own; check with a clinician or pharmacist. **Sources:** - [Managing Chronic Kidney Disease (medicines)](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/managing) — NIH / NIDDK - [Which Drugs Are Harmful to Your Kidneys?](https://www.kidney.org/kidney-topics/which-drugs-are-harmful-to-your-kidneys) — National Kidney Foundation ### Home blood-pressure monitoring **Because blood pressure both drives and reflects kidney disease, checking it at home with a validated monitor helps the care team manage it to target between visits.** Blood pressure sits at the center of CKD care — high pressure damages the kidneys, and CKD raises blood pressure — so keeping it well controlled is one of the most effective ways to slow decline and protect the heart. Home monitoring is valuable because it captures blood pressure in everyday life, away from the 'white-coat' effect of clinics, and gives the care team more data to adjust treatment between visits. Using a validated upper-arm cuff, following correct technique (resting first, feet flat, arm supported at heart level, several readings), and recording the results to share at appointments all improve usefulness. The right blood-pressure target is individualized — often lower for people with CKD and albuminuria — and is set by the care team, who also adjust medicines based on the readings and on kidney function and potassium tests. Home monitoring empowers a person to take part in their care, but it complements rather than replaces professional management of the numbers and medications. **Sources:** - [High Blood Pressure & Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/high-blood-pressure) — NIH / NIDDK - [Monitoring Your Blood Pressure at Home](https://www.heart.org/en/health-topics/high-blood-pressure/understanding-blood-pressure-readings/monitoring-your-blood-pressure-at-home) — American Heart Association ### Vaccines and preventing infection **CKD raises the risk and severity of some infections, so recommended vaccinations (including hepatitis B for those heading toward dialysis) and everyday infection prevention are important parts of care.** People with CKD, and especially those with advanced disease or on dialysis or after a transplant, can be more vulnerable to infections and to their complications, partly because kidney disease and its treatments can weaken immune defenses. Staying current with recommended vaccinations is therefore an important, often-overlooked part of CKD care: this typically includes influenza, COVID-19, and pneumococcal (pneumonia) vaccines, and hepatitis B vaccination is specifically recommended for people approaching dialysis (since the dialysis setting carries exposure risk and protection is best established in advance). Transplant recipients have particular vaccine timing considerations because of their anti-rejection medicines. Beyond vaccines, everyday measures — hand hygiene, careful care of any dialysis access or catheter, prompt attention to possible infections, and good foot and skin care in those with diabetes — reduce risk. The specific vaccines and timing appropriate for an individual are guided by the care team based on their stage and treatment. **Sources:** - [Vaccines for Adults with Chronic Kidney Disease](https://www.kidney.org/kidney-topics/vaccines-for-adults-with-chronic-kidney-disease) — National Kidney Foundation - [Vaccines and Kidney Disease](https://www.kidneyfund.org/resource/vaccines-and-kidney-disease) — American Kidney Fund ### Mental health and coping **Depression, anxiety, and stress are common with CKD — especially as it advances or with dialysis — and they affect self-care, so emotional support is a legitimate, important part of care.** Living with a progressive chronic illness, facing decisions about dialysis or transplant, and managing a demanding daily routine all take an emotional toll, and depression and anxiety are notably more common in people with CKD than in the general population — particularly in advanced CKD and among those on dialysis. This matters not only for wellbeing but because low mood and stress can undermine the day-to-day self-care that CKD requires, creating a cycle that worsens both. Recognizing that these feelings are common and treatable is the first step. Help can come in many forms: talking with the care team (who can screen for and treat depression and anxiety), counseling or therapy, peer support and patient communities, dialysis-unit social workers, and support for caregivers, who also carry a load. Some treatments are adjusted for kidney function, so any medication for mood is coordinated with the team. Attending to mental health is not optional or secondary — it is part of comprehensive kidney care and supports better physical outcomes. **Sources:** - [Managing Your Emotions While Living with Kidney Disease](https://www.kidney.org/kidney-topics/managing-your-emotions-while-living-kidney-disease) — National Kidney Foundation - [Managing Chronic Kidney Disease (emotional health)](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/managing) — NIH / NIDDK ### Building your care team **CKD care often involves a primary clinician, a nephrologist, a dietitian, a pharmacist, and others; knowing who does what and when to involve a specialist helps coordinate care.** Because CKD touches so many parts of health, it is usually managed by a team rather than a single doctor, and understanding the team helps a person get the right care at the right time. A primary care clinician often coordinates overall health and early CKD, while a nephrologist (kidney specialist) is typically involved as CKD advances — commonly when eGFR falls below about 30, when there is significant albuminuria, rapid decline, difficult-to-control blood pressure, or an uncertain cause — to guide kidney-specific treatment and prepare for kidney failure if needed. A renal dietitian individualizes nutrition, a pharmacist helps keep the medication list safe and correctly dosed for kidney function, and dialysis nurses, social workers, and transplant teams join when relevant. Knowing who to contact for what, asking questions, and bringing an up-to-date medication and results list to visits all help the team work together. Good coordination — with the person at the center — is what makes complex, multi-faceted CKD care coherent and effective. **Sources:** - [Managing Chronic Kidney Disease (your health care team)](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/managing) — NIH / NIDDK - [Your Kidney Care Team](https://www.kidney.org/kidney-topics/health-care-team) — National Kidney Foundation --- ## Complications of CKD The downstream effects of declining kidney function — anemia of CKD, mineral and bone disorder (CKD-MBD), cardiovascular disease (the leading cause of death in CKD), metabolic acidosis, high potassium, and fluid/blood-pressure problems. ### Anemia of CKD _(Established)_ **As kidneys fail, they make less erythropoietin, the hormone that drives red-blood-cell production, so anemia develops — causing fatigue and breathlessness — and is treatable.** Healthy kidneys make a hormone called erythropoietin (EPO) that signals the bone marrow to produce red blood cells. As CKD advances, EPO production falls, and — often compounded by iron deficiency and inflammation — anemia (a low red-blood-cell count) develops, becoming more common as kidney function declines and affecting nearly everyone with kidney failure. Because red blood cells carry oxygen, anemia causes symptoms such as fatigue, weakness, shortness of breath, paleness, dizziness, and trouble concentrating, and it can worsen heart strain. The good news is that anemia of CKD is treatable: management typically starts by checking and correcting iron levels (with oral or intravenous iron), and may include erythropoiesis-stimulating agents (lab-made versions of EPO) or, more recently, oral medicines called HIF-PH inhibitors, with the goal of easing symptoms without overcorrecting. Because both too-low and too-high red-cell levels carry risks, anemia treatment is carefully monitored and individualized by the care team, guided by regular blood tests. **Sources:** - [Anemia in Chronic Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/anemia) — NIH / NIDDK - [Anemia and Chronic Kidney Disease](https://www.kidney.org/kidney-topics/anemia-and-chronic-kidney-disease) — National Kidney Foundation ### CKD–mineral and bone disorder (CKD-MBD) _(Established)_ **Failing kidneys disturb the balance of calcium, phosphorus, vitamin D, and parathyroid hormone, weakening bones and promoting calcium buildup in blood vessels — a silent process that develops over years.** The kidneys help regulate calcium and phosphorus and activate vitamin D, and they respond to parathyroid hormone (PTH), so as they fail this whole system gets out of balance — a condition called CKD–mineral and bone disorder (CKD-MBD). Typically phosphorus rises (because the kidneys cannot excrete it), active vitamin D falls, blood calcium can drop, and the parathyroid glands respond by pumping out more PTH, which pulls calcium from the bones. Over years this weakens and deforms bones (raising fracture risk) and, just as importantly, drives calcium deposits into blood vessels and the heart, contributing to the cardiovascular disease that is the leading killer in CKD. CKD-MBD usually causes no symptoms until advanced, so it is detected through blood tests for phosphorus, calcium, PTH, and vitamin D, and is managed with dietary phosphorus control, phosphate-binder medicines, vitamin D and related treatments, and (in some) drugs that lower PTH — all individualized and monitored by the care team. Its link to both bones and the heart is why it is taken seriously even when silent. **Sources:** - [Mineral and Bone Disorder (CKD-MBD)](https://www.kidney.org/kidney-topics/mineral-and-bone-disorder-ckd-mbd) — National Kidney Foundation - [KDIGO Clinical Practice Guideline for CKD-MBD](https://kdigo.org/guidelines/ckd-mbd/) — KDIGO ### Cardiovascular disease (the leading cause of death) _(Established)_ **CKD greatly increases the risk of heart attack, stroke, and heart failure, and cardiovascular disease — not kidney failure itself — is the most common cause of death in people with CKD.** One of the most important facts about CKD is that its biggest danger is often to the heart, not the kidneys: people with CKD are far more likely to die from cardiovascular disease — heart attack, stroke, heart failure — than to reach kidney failure, and CKD is recognized as a powerful independent risk factor for cardiovascular events. The reasons are intertwined: CKD shares causes with heart disease (diabetes, high blood pressure), and it adds its own harms, including high blood pressure, fluid overload, anemia, mineral-bone disorder with vascular calcification, inflammation, and abnormal lipids. This is why CKD care is, to a large degree, heart-protective care: controlling blood pressure, using kidney-and-heart-protective medicines (ACE inhibitors/ARBs, SGLT2 inhibitors, finerenone), managing cholesterol (often with a statin), not smoking, and staying active all aim at this overarching risk. Understanding the heart-kidney link reframes CKD management — slowing kidney decline and protecting the heart are two sides of the same effort, pursued together by the care team. **Sources:** - [Heart Disease & Chronic Kidney Disease (CKD)](https://www.kidney.org/kidney-topics/heart-and-kidney-connection) — National Kidney Foundation - [Chronic Kidney Disease, Diabetes, and Heart Disease](https://www.cdc.gov/kidney-disease/risk-factors/link-between-diabetes-and-heart-disease.html) — CDC ### Metabolic acidosis **Failing kidneys may not remove enough acid from the body, making the blood too acidic; over time this can speed kidney decline and harm bone and muscle, and it is treatable.** Part of the kidneys' job is to remove acid that the body produces and to maintain the blood's acid-base balance. In CKD, the kidneys may not keep up, allowing acid to accumulate — a condition called metabolic acidosis, often detected as a low bicarbonate level on blood tests. While mild acidosis may cause no obvious symptoms, over time it can contribute to faster loss of kidney function, loss of muscle mass, bone problems, and worsening of other CKD complications. Because it is usually silent, it is found through routine blood testing rather than symptoms. Treatment, when needed, may include dietary adjustments (sometimes more fruits and vegetables, balanced against potassium considerations) and oral alkali therapy such as sodium bicarbonate to bring the bicarbonate level back toward normal, which may help protect the kidneys and bones. The decision to treat and how to do so is guided by the care team based on blood results, balancing acidosis against sodium and potassium. **Sources:** - [Metabolic Acidosis](https://www.kidney.org/kidney-topics/metabolic-acidosis) — National Kidney Foundation - [Managing Chronic Kidney Disease (complications)](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/managing) — NIH / NIDDK ### High potassium (chronic hyperkalemia) **Beyond acute emergencies, persistently high potassium is an ongoing complication of advanced CKD that constrains diet and some kidney-protective medicines, and is managed with monitoring and treatment.** High blood potassium (hyperkalemia) is covered as an emergency elsewhere, but it is also a chronic management challenge in CKD. As kidney function declines, the kidneys clear potassium less effectively, so levels tend to run higher, and this is compounded by some of the very medicines that protect the kidneys and heart — ACE inhibitors, ARBs, and finerenone can each raise potassium. The result is a balancing act: these beneficial drugs sometimes cannot be used at full dose, or require extra monitoring, because of potassium. Chronic hyperkalemia is managed through regular blood-potassium checks, dietary guidance (limiting high-potassium foods when needed, and avoiding potassium-based salt substitutes), reviewing contributing medications, and, in some people, potassium-binder medicines that help the body remove potassium and can allow the kidney-protective drugs to be continued. Because potassium control affects both safety and access to important treatments, it is actively managed by the care team rather than left to chance, and any dietary or medication changes for potassium should go through them. **Sources:** - [High Potassium (Hyperkalemia): Causes, Symptoms, and Treatment](https://www.kidney.org/kidney-topics/hyperkalemia-high-potassium) — National Kidney Foundation - [High Potassium (Hyperkalemia): Causes, Prevention and Treatment](https://www.kidneyfund.org/living-kidney-disease/health-problems-caused-kidney-disease/high-potassium-hyperkalemia-causes-prevention-and-treatment) — American Kidney Fund ### Fluid retention and worsening blood pressure **As kidneys lose the ability to balance salt and water, fluid retention and rising blood pressure become common complications that strain the heart and, in turn, the kidneys.** Among the kidneys' core jobs is balancing salt and water and helping regulate blood pressure, so as CKD advances these functions falter, producing two linked complications. Fluid retention shows up as swelling (in the legs, ankles, or around the eyes), weight gain, and — when severe — fluid backing up into the lungs and causing breathlessness; it is more pronounced in advanced CKD and kidney failure. At the same time, blood pressure tends to rise, both because the kidneys handle fluid poorly and because of disturbed pressure-regulating hormones, and high blood pressure then further damages the kidneys and heart in a vicious cycle. Managing these involves limiting dietary sodium, sometimes restricting fluids in advanced disease, diuretic ('water pill') medicines to help remove excess fluid, blood-pressure medicines, and — in kidney failure — dialysis to remove fluid. Tracking weight and blood pressure helps catch problems early. These complications underline why sodium, fluid, and blood-pressure management are so central to CKD care, all coordinated with the care team. **Sources:** - [Fluid Overload in a Dialysis Patient](https://www.kidney.org/kidney-topics/fluid-overload-dialysis-patient) — National Kidney Foundation - [High Blood Pressure & Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/high-blood-pressure) — NIH / NIDDK --- ## Key Drug Interactions Educational overview of medication concerns in CKD — renal dosing, nephrotoxins to be aware of (NSAIDs, contrast dye, certain antibiotics, some herbals), potassium-raising combinations, and metformin/SGLT2 cautions. Always have a pharmacist or clinician check actual medicines. ### How to think about medicines with kidney disease **When kidneys are impaired, two things matter: many drugs need dose adjustment, and some can further harm the kidneys; the safe move is one full medication list checked by a pharmacist — not self-judging 'safe' or 'unsafe.'** Kidney disease changes the medication picture in two key ways. First, the kidneys clear many drugs from the body, so reduced kidney function can let some medicines build up to harmful levels unless the dose is adjusted or the drug avoided — this is 'renal dosing.' Second, certain medicines and substances can directly worsen kidney function (nephrotoxins) or raise potassium dangerously. The entries here explain the best-known concerns so a person can recognize and ask about them, but they are not a substitute for an authoritative check: whether a given medicine or combination is a problem depends on the individual's kidney function, other conditions, and the rest of their regimen — exactly the judgment a pharmacist or prescriber is trained to make. Habits that genuinely reduce risk: keep one up-to-date list of every prescription, over-the-counter product, vitamin, and herbal supplement; mention you have kidney disease (and your latest eGFR) with every new medicine and before any scan or procedure; and use one pharmacy so interactions and renal dosing are screened. Never treat any entry here as a definitive ruling. > **Note:** Educational only — not an interaction or dosing check. Have a pharmacist or clinician review your actual medicines and supplements against your kidney function; this is never a definitive safe/unsafe ruling. **Sources:** - [Safe Medicine Use with Chronic Kidney Disease](https://www.kidney.org/kidney-topics/safe-medicine-use-chronic-kidney-disease) — National Kidney Foundation - [Which Drugs Are Harmful to Your Kidneys?](https://www.kidney.org/kidney-topics/which-drugs-are-harmful-to-your-kidneys) — National Kidney Foundation ### NSAID pain relievers _(Established)_ **NSAIDs like ibuprofen and naproxen reduce blood flow to the kidneys and can worsen kidney function, especially with regular use or alongside ACE inhibitors/ARBs and diuretics.** Nonsteroidal anti-inflammatory drugs (NSAIDs) — including common over-the-counter pain relievers such as ibuprofen and naproxen — are among the medications people with CKD most need to be careful with. NSAIDs reduce blood flow to the kidneys, which can acutely worsen kidney function, and regular or high-dose use over time has been linked to kidney damage. The risk is higher in people who already have reduced kidney function, heart disease, or high blood pressure, and it is compounded when NSAIDs are combined with ACE inhibitors or ARBs and a diuretic (sometimes called the 'triple whammy'), a combination particularly associated with acute kidney injury. Because NSAIDs are sold without a prescription and are easy to reach for, this is a frequently missed risk. People with CKD are often advised to limit or avoid NSAIDs and to ask about alternative pain relief — but which painkillers are appropriate for an individual is a question for the clinician or pharmacist, not a self-decision. > **Note:** NSAIDs can worsen kidney function, especially with an ACE inhibitor/ARB plus a diuretic. Ask a clinician or pharmacist about safer pain relief before using them. **Sources:** - [Pain Medications for CKD: Risks, Safety, and Alternatives](https://www.kidney.org/kidney-topics/pain-medicines-and-kidney-disease) — National Kidney Foundation - [Which Drugs Are Harmful to Your Kidneys? (NSAIDs)](https://www.kidney.org/kidney-topics/which-drugs-are-harmful-to-your-kidneys) — National Kidney Foundation ### Iodinated contrast dye (for scans) _(Established)_ **The iodine-based contrast dye used in some CT scans and angiograms can occasionally worsen kidney function; precautions are taken in people with reduced eGFR, so always mention your kidney disease before a scan.** Some imaging tests — certain CT scans, angiograms, and catheter procedures — use an iodine-based contrast dye to make blood vessels and tissues visible. In people with reduced kidney function, this contrast can occasionally cause a temporary worsening of kidney function (contrast-associated acute kidney injury), though for most people with mild CKD the risk is low and is weighed against the value of the scan. To reduce risk, clinicians take precautions in higher-risk people, such as ensuring good hydration, using the smallest necessary amount of contrast, and sometimes adjusting or pausing certain medicines around the scan (for example metformin or diuretics). A separate, rare concern with gadolinium contrast (used in some MRIs) exists in severe kidney impairment. The practical takeaway for a person with CKD is simple but important: always tell the team ordering and performing any scan that you have kidney disease and, if known, your eGFR, so they can decide on contrast and precautions — these are clinical decisions, not ones to make alone. > **Note:** Always tell the team you have kidney disease before any scan with contrast dye, so they can take precautions and decide about medicines like metformin — don't assume it's fine or pause medicines yourself. **Sources:** - [Five Surprising Ways You Could Be Damaging Your Kidneys (contrast dye)](https://www.kidney.org/kidney-topics/five-surprising-ways-you-could-be-damaging-your-kidneys) — National Kidney Foundation - [Contrast Dye and the Kidneys](https://www.kidney.org/kidney-topics/contrast-dye-and-kidneys) — National Kidney Foundation ### Antibiotics and other drugs needing renal dosing _(Established)_ **Some antibiotics (such as aminoglycosides) can be directly toxic to the kidneys, and many antibiotics and other drugs need their dose adjusted for kidney function to avoid harmful buildup.** Antibiotics illustrate both medication risks in CKD. A few are directly nephrotoxic — aminoglycoside antibiotics (such as gentamicin and tobramycin) are well known for being able to damage the kidneys, so they are used carefully, with monitoring, in people with reduced kidney function. More broadly, many antibiotics — and many other medicines, including some antivirals, certain diabetes and heart drugs, and others — are cleared by the kidneys and need their dose or frequency adjusted (or need avoiding) when kidney function is reduced, because the normal dose could accumulate to toxic levels. This is why the prescriber and pharmacist check kidney function (eGFR) when choosing and dosing medicines, and why mentioning your CKD at every new prescription is so important — a dose that is right for normal kidneys can be too much for impaired ones. Other agents to be aware of include some bowel-prep products and certain proton-pump inhibitors with long-term use. The specifics of which drugs and what doses are appropriate are determined by the clinical team using kidney function, not by the patient. > **Note:** Many antibiotics and other drugs need dose adjustment for kidney function — tell every prescriber and pharmacist you have CKD so the dose can be checked. **Sources:** - [Which Drugs Are Harmful to Your Kidneys? (antibiotics and others)](https://www.kidney.org/kidney-topics/which-drugs-are-harmful-to-your-kidneys) — National Kidney Foundation - [Safe Medicine Use with Chronic Kidney Disease](https://www.kidney.org/kidney-topics/safe-medicine-use-chronic-kidney-disease) — National Kidney Foundation ### Medicines and products that raise potassium _(Established)_ **Several kidney-protective drugs (ACE inhibitors, ARBs, finerenone) and some others raise blood potassium, and combined with potassium-based salt substitutes or supplements this can become dangerous.** Because high potassium is a special hazard in CKD, it is worth knowing which medicines and products can raise it. Several of the most kidney-and-heart-protective drugs — ACE inhibitors, ARBs, and the newer agent finerenone — can increase blood potassium, which is why potassium is monitored when they are started or increased, and occasionally limits their dose. Other potassium-raising medicines include potassium-sparing diuretics (such as spironolactone) and potassium supplements themselves. A frequently overlooked source is potassium-based salt substitutes (often marketed as 'low-sodium' or 'lite' salt), which can deliver a large potassium load and have caused dangerous hyperkalemia in people with CKD. Combining several potassium-raising factors — the protective drugs, supplements, salt substitutes, and a high-potassium diet — multiplies the risk. This does not mean the beneficial drugs should be avoided; it means potassium is watched and managed so they can be used safely. Any decision about these medicines, supplements, or salt substitutes belongs with the care team and pharmacist. > **Note:** Potassium-based salt substitutes and supplements can be dangerous in CKD, especially alongside ACE inhibitors, ARBs, or finerenone — check with the care team before using them. **Sources:** - [High Potassium (Hyperkalemia): Causes, Symptoms, and Treatment](https://www.kidney.org/kidney-topics/hyperkalemia-high-potassium) — National Kidney Foundation - [ACE Inhibitors and ARBs (potassium monitoring)](https://www.kidney.org/kidney-topics/ace-inhibitors-and-arbs) — National Kidney Foundation ### Metformin, SGLT2 inhibitors, and 'sick-day' cautions _(Established)_ **Some diabetes medicines have kidney-related cautions — metformin needs dose limits or holding in reduced function and around contrast, and SGLT2 inhibitors are paused during illness and surgery.** Two widely used diabetes medicines that also feature in kidney care carry specific renal cautions. Metformin is cleared by the kidneys, so it is dose-limited or avoided when kidney function is significantly reduced, and is commonly paused around iodinated-contrast scans, major surgery, and acute illnesses with dehydration, to lower the rare risk of a serious condition called lactic acidosis; it is restarted once kidney function is confirmed stable. SGLT2 inhibitors, though kidney-protective and a mainstay of CKD treatment, are typically paused during significant acute illness and before planned surgery because of a rare risk of (sometimes euglycemic) ketoacidosis, and they can add to dehydration alongside diuretics. More generally, many people with CKD are given 'sick-day' guidance about which medicines may need temporary holding during illnesses with vomiting, diarrhea, or poor intake — often including ACE inhibitors/ARBs, diuretics, metformin, SGLT2 inhibitors, and NSAIDs — to protect the kidneys. Crucially, exactly which medicines to hold, and when to restart them, are decisions to confirm with the clinician or pharmacist, never to guess. > **Note:** Don't pause or restart medicines like metformin or SGLT2 inhibitors on your own for illness, scans, or surgery — confirm sick-day guidance with your clinician or pharmacist. **Sources:** - [Safe Medicine Use with Chronic Kidney Disease (sick-day and diabetes medicines)](https://www.kidney.org/kidney-topics/safe-medicine-use-chronic-kidney-disease) — National Kidney Foundation - [Metformin — cautions, kidney function and procedures](https://www.nhs.uk/medicines/metformin/) — NHS (UK) --- ## Comorbidities & Co-occurring Conditions What commonly co-occurs with CKD and why it compounds — the cardiovascular–kidney–metabolic cluster (diabetes, high blood pressure, heart disease), gout, mental health conditions, and the resulting polypharmacy. The grounding for multi-condition reasoning. ### CKD rarely travels alone **Most people with CKD have other chronic conditions — above all diabetes, high blood pressure, and heart disease — which both cause CKD and are worsened by it, so care must treat the whole person.** Chronic kidney disease seldom occurs in isolation. Its leading causes — diabetes and high blood pressure — are themselves chronic conditions that persist alongside the CKD they create, and CKD in turn worsens them and drives new problems, especially heart disease. The overlaps run in both directions and compound each other: the same processes that damage kidneys damage the heart and blood vessels, and failing kidneys raise blood pressure, disturb minerals, and add cardiovascular risk. This is why good CKD care looks well beyond the kidneys to blood pressure, blood sugar, the heart, lipids, weight, mental health, and more, and why coordination across the care team matters so much. The conditions also create compounding and sometimes conflicting management considerations — a treatment ideal for one condition must be weighed against its effect on another, and several conditions together mean many medicines. The entries here map the most common co-occurring conditions and how they interact, as grounding for thinking about more than one condition at once. **Sources:** - [Chronic Kidney Disease (CKD) — risk factors and related conditions](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd) — NIH / NIDDK - [Chronic Kidney Disease, Diabetes, and Heart Disease](https://www.cdc.gov/kidney-disease/risk-factors/link-between-diabetes-and-heart-disease.html) — CDC ### The cardiovascular–kidney–metabolic cluster _(Established)_ **Diabetes, high blood pressure, heart disease, and CKD form a tightly linked cluster that shares drivers and worsens one another — but several modern treatments protect kidney and heart together.** CKD is at the center of what is increasingly described as cardiovascular–kidney–metabolic (CKM) syndrome: the tight clustering of excess weight and metabolic problems, type 2 diabetes, high blood pressure, heart disease, and kidney disease. These conditions share underlying drivers (insulin resistance, high blood pressure, abnormal lipids, inflammation, and blood-vessel damage) and each accelerates the others — diabetes and hypertension damage the kidneys and heart, CKD raises blood pressure and cardiovascular risk, and heart failure and kidney disease worsen each other (the 'cardiorenal' link). This compounding is why management is integrated rather than siloed, and it shapes treatment in a helpful way: SGLT2 inhibitors, finerenone, GLP-1 receptor agonists, and ACE inhibitors/ARBs are favored precisely because they protect the kidney and the heart at once. The flip side is complexity — overlapping risks, many medications, and the need to monitor kidney function, potassium, and volume — which makes this cluster the prime example of why multi-condition CKD care must be coordinated as a whole. **Sources:** - [Cardiovascular-Kidney-Metabolic (CKM) Health](https://www.heart.org/en/health-topics/cardiovascular-kidney-metabolic-syndrome) — American Heart Association - [Diabetic Kidney Disease (diabetes, kidney, and heart links)](https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/diabetic-kidney-disease) — NIH / NIDDK ### Diabetes and CKD together _(Established)_ **Diabetes is the leading cause of CKD, and the two together demand coordinated control of blood sugar, blood pressure, and kidney-protective medicines, with special attention to drugs cleared by the kidney.** Diabetes and CKD are deeply entwined: diabetes is the single biggest cause of kidney disease, and having both substantially raises the risk of kidney failure and cardiovascular events. Managing them together is more than the sum of the parts. Glucose control helps protect the kidneys, but as kidney function declines some diabetes medicines need dose adjustment or avoidance (for example metformin), and the risk of low blood sugar can rise because the kidneys clear insulin and some drugs more slowly — so targets are sometimes relaxed to avoid dangerous lows. At the same time, several diabetes medicines (SGLT2 inhibitors, GLP-1 receptor agonists) and the diabetes-CKD drug finerenone are chosen specifically for their kidney and heart protection. Blood-pressure control (often with an ACE inhibitor or ARB) and yearly urine ACR testing are core to diabetic kidney care. The result is a regimen that must satisfy diabetes, kidney, and heart goals simultaneously — a balancing act best handled by a coordinated care team rather than treating each condition in isolation. **Sources:** - [Diabetic Kidney Disease](https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/diabetic-kidney-disease) — NIH / NIDDK - [Diabetes and Kidney Disease (Stages 1–4)](https://www.kidney.org/kidney-topics/diabetes-and-kidney-disease-stages-1-4) — National Kidney Foundation ### High blood pressure and heart disease _(Established)_ **High blood pressure both causes and results from CKD, and heart disease is the leading cause of death in CKD; managing them is inseparable from managing the kidneys.** High blood pressure and heart disease are the comorbidities most tightly bound to CKD. Hypertension has a two-way relationship with the kidneys — it damages them, and damaged kidneys raise blood pressure — so controlling it (often with an ACE inhibitor or ARB) is simultaneously kidney-protective and heart-protective. Heart disease, meanwhile, is the most common cause of death in people with CKD, fueled by shared risk factors plus CKD-specific harms like fluid overload, anemia, and vascular calcification from mineral-bone disorder. Heart failure and CKD are especially interdependent (the 'cardiorenal syndrome'), where treating one carefully affects the other — for instance, diuretics to relieve fluid must be balanced against kidney function and electrolytes. Because of all this, CKD care devotes major attention to blood pressure, cholesterol (commonly a statin), and cardiovascular risk, and several CKD medicines were adopted precisely for their cardiovascular benefit. Coordinating kidney and heart care — rather than optimizing one at the other's expense — is central, and it is the care team's job. **Sources:** - [Heart Disease & Chronic Kidney Disease (CKD)](https://www.kidney.org/kidney-topics/heart-and-kidney-connection) — National Kidney Foundation - [High Blood Pressure & Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/high-blood-pressure) — NIH / NIDDK ### Gout, mental health, and other co-occurring conditions **CKD also commonly travels with gout (the kidneys handle uric acid), depression and anxiety, sleep problems, and anemia and bone disease — several of which both affect and are affected by kidney function.** Beyond the central cardiometabolic cluster, several other conditions accompany CKD. Gout is notably more common because the kidneys normally clear uric acid, so reduced function lets it accumulate; gout management is complicated by CKD because some gout medicines need dose adjustment and NSAIDs (often used for flares) can harm the kidneys, requiring careful choices. Mental health conditions — depression, anxiety, and the stress of a progressive illness — are more frequent in CKD and can undermine self-care, so they are an important comorbidity rather than a side issue. Sleep problems (including sleep apnea, itself linked to high blood pressure and heart risk) are common too. CKD's own complications — anemia and mineral-bone disorder — function as co-occurring conditions that need their own monitoring and treatment. Many people with CKD therefore live with several interacting conditions at once, which is the reality that multi-condition care must address: screening for them, and managing them in a coordinated way that respects how each affects the kidneys and the others. **Sources:** - [Quick Facts: Gout and Chronic Kidney Disease](https://www.kidney.org/kidney-topics/quick-facts-gout-and-chronic-kidney-disease) — National Kidney Foundation - [Managing Your Emotions While Living with Kidney Disease](https://www.kidney.org/kidney-topics/managing-your-emotions-while-living-kidney-disease) — National Kidney Foundation ### Polypharmacy and coordinating multiple conditions **Several conditions mean several medicines — many needing renal dosing — which raises interaction and side-effect risks; coordinated review, including by a pharmacist, keeps the combined plan safe.** Because CKD so often comes with diabetes, high blood pressure, heart disease, gout, anemia, bone-mineral disorder, and more, many people with CKD end up taking numerous medicines — polypharmacy. Each may be individually appropriate, but together they raise the risk of interactions and cumulative side effects, and the kidney dimension adds a twist: many drugs need dose adjustment for kidney function, and some must be avoided, so the combined regimen must be both internally compatible and correctly dosed for the person's eGFR. Conditions can also pull in different directions — the ideal treatment for one may stress the kidneys or raise potassium — so goals are individualized, sometimes relaxing targets (for example to avoid hypoglycemia in frail older adults). Managing this well relies on coordination: a care team that sees the whole picture, periodic medication review and reconciliation (a role pharmacists are especially suited to), renal dose checks, deprescribing what is no longer needed, and simplifying where possible. The combined plan — not any single condition's ideal in isolation — is what good multi-condition CKD care optimizes, always with professional oversight. > **Note:** When several conditions and medicines stack up in CKD, ask for a medication review with the care team or pharmacist — coordinating the whole plan, with renal dosing, is safer than optimizing one condition alone. **Sources:** - [Safe Medicine Use with Chronic Kidney Disease](https://www.kidney.org/kidney-topics/safe-medicine-use-chronic-kidney-disease) — National Kidney Foundation - [Managing Chronic Kidney Disease (working with your care team)](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/managing) — NIH / NIDDK --- ## Experimental & Emerging Therapies Frontier directions in kidney disease — pig-kidney xenotransplantation, the bioartificial/wearable kidney, HIF-PH inhibitors for anemia, regenerative approaches, and precision-medicine research — reported with honest evidence levels and a caution about unproven clinics. ### Pig-kidney xenotransplantation _(Investigational)_ **Gene-edited pig kidneys are being transplanted into humans in early experimental cases and first clinical trials, aiming to ease the severe donor-organ shortage — but this is very early and not standard care.** One of the most closely watched frontiers is xenotransplantation: transplanting kidneys from genetically modified pigs into people, to address the chronic shortage of human donor organs. Using pigs with gene edits intended to reduce immune rejection, surgical teams in the U.S. performed the first transplants of gene-edited pig kidneys into living recipients in 2024, and the FDA has since cleared the first formal clinical trials to study the approach more rigorously. Early cases have shown both promise and the field's immaturity — some recipients survived for weeks to months, and outcomes have been mixed, with rejection and complications remaining major challenges. This is genuinely groundbreaking but firmly experimental: it is not an available or proven treatment, long-term safety and durability are unknown, and the risk of transmitting animal viruses is carefully studied. Xenotransplantation could one day expand options for kidney failure, but for now it exists only within tightly regulated research. > **Note:** Xenotransplantation is experimental and available only in regulated research — it is not an approved or proven treatment. **Sources:** - [FDA Greenlights First Clinical Trials for Genetically Modified Pig Kidney Transplants in Humans](https://www.kidneyfund.org/article/fda-greenlights-first-clinical-trials-genetically-modified-pig-kidney-transplants-humans) — American Kidney Fund - [First Gene-Edited Pig Kidney Transplant Clinical Trial Begins at NYU Langone Health](https://nyulangone.org/news/first-gene-edited-pig-kidney-transplant-clinical-trial-begins-nyu-langone-health) — NYU Langone Health ### The bioartificial and wearable artificial kidney _(Investigational)_ **Researchers are developing an implantable bioartificial kidney and wearable dialysis devices that could one day filter blood continuously without a machine or immunosuppression — still preclinical or early-stage.** Another major research direction aims to replace or improve on conventional dialysis with new devices. The Kidney Project, a national effort, is developing an implantable bioartificial kidney — roughly the size of a coffee cup — that combines a blood filter with living kidney cells to perform some functions of a real kidney continuously, with the hope of freeing people from dialysis schedules and, because of its design, potentially without the immunosuppression a transplant requires. Its components have worked together in animal-scale prototypes, and developers are building toward human trials, but it is not yet tested in people and timelines remain uncertain. In parallel, wearable and more portable dialysis devices are being explored to make treatment more continuous and less disruptive than current machines. These technologies are exciting and could transform kidney-failure care, but they are at the preclinical or early-development stage — promising directions, not available treatments. Progress depends on further engineering, testing, and funding. > **Note:** The bioartificial and wearable kidney are in development and not yet available or proven in people. **Sources:** - [The Kidney Project (implantable bioartificial kidney)](https://pharm.ucsf.edu/kidney) — UCSF School of Pharmacy - [Emerging Innovations in Kidney Disease Research](https://www.kidneyfund.org/article/emerging-innovations-kidney-disease-research-kidney-project-xenotransplantation-and-kidney-precision) — American Kidney Fund ### HIF-PH inhibitors for anemia (e.g. daprodustat) _(Emerging)_ **A newer class of oral medicines for anemia of CKD stabilizes the body's oxygen-sensing pathway to boost red-cell production; in the U.S. one (daprodustat) is approved, but only for adults on dialysis.** A newer approach to the anemia of CKD uses oral drugs called HIF-prolyl hydroxylase inhibitors (HIF-PH inhibitors), which work by stabilizing hypoxia-inducible factor — the body's natural oxygen-sensing system — prompting more erythropoietin and improving iron use to raise red-blood-cell counts. Their appeal is that they are taken by mouth, unlike the injected erythropoiesis-stimulating agents long used for CKD anemia. In the U.S., daprodustat (Jesduvroq) was approved by the FDA in 2023 — the first oral agent for CKD anemia in decades — but with a notably narrow indication: only for adults who have been on dialysis for at least four months, and not for people with CKD who are not on dialysis. This cautious scope reflects ongoing attention to the class's safety, including cardiovascular considerations, and regulatory decisions have differed between countries. HIF-PH inhibitors represent a real but still-evolving addition to anemia care, and whether one is appropriate is a decision for the care team. **Sources:** - [Jesduvroq (daprodustat) Approved by US FDA for Anemia of CKD in Adults on Dialysis](https://us.gsk.com/en-us/media/press-releases/jesduvroq-daprodustat-approved-by-us-fda-for-anemia-of-chronic-kidney-disease-in-adults-on-dialysis/) — GSK, 2023 - [Anemia in Chronic Kidney Disease](https://www.niddk.nih.gov/health-information/kidney-disease/anemia) — NIH / NIDDK ### Regenerative medicine and cell-based research _(Preliminary)_ **Scientists are exploring cell therapies, lab-grown kidney tissue (organoids), and ways to slow scarring, aiming to repair or regenerate kidney function — but these remain laboratory and early research.** A broad research field seeks to repair, regenerate, or replace kidney tissue rather than just slow decline. Approaches under study include cell-based therapies intended to reduce inflammation and scarring or support kidney repair, growing miniature kidney structures called organoids from stem cells to study disease and test drugs (and, far in the future, perhaps to build replacement tissue), and drugs aimed at the fibrosis (scarring) that drives CKD progression. Some early-stage cell therapies are being tested in clinical trials for specific kidney diseases. These efforts are scientifically promising and could eventually change what is possible, but the great majority remain in the laboratory or in early human studies, and none has become an established treatment that reverses chronic kidney damage. Realistic framing matters here: regenerating a damaged kidney is a hard problem, progress is incremental, and today's proven care still centers on slowing progression and replacing function with dialysis or transplant. Any participation in this research is through legitimate, regulated clinical trials. **Sources:** - [Kidney Disease Research (NIDDK research area)](https://www.niddk.nih.gov/about-niddk/research-areas/kidney-disease) — NIH / NIDDK - [Emerging Innovations in Kidney Disease Research](https://www.kidneyfund.org/article/emerging-innovations-kidney-disease-research-kidney-project-xenotransplantation-and-kidney-precision) — American Kidney Fund ### Precision medicine and the Kidney Precision Medicine Project _(Emerging)_ **Large research efforts are mapping kidney disease at the molecular and cellular level to define subtypes and find new targets, aiming to move toward more individualized treatment in the future.** Much of CKD is still classified broadly (for example 'diabetic kidney disease'), but research increasingly suggests it is many different diseases at the molecular level, which may respond to different treatments. The Kidney Precision Medicine Project (KPMP), funded by the NIH/NIDDK, is a major effort to study kidney tissue from people with CKD and acute kidney injury in detail — mapping the cells and molecular changes involved — to define disease subtypes, identify new treatment targets, and ultimately enable more precise, individualized care. This kind of precision-medicine research is foundational rather than an immediate therapy: it builds the understanding from which future treatments and better-targeted use of existing ones can come. It reflects a broader shift in kidney medicine toward understanding the biology of each person's disease rather than treating CKD as one uniform condition. For now its impact is on research and the development pipeline, with benefits to patients expected to unfold over years as discoveries translate into new options. **Sources:** - [Kidney Precision Medicine Project (KPMP) — FAQ](https://www.niddk.nih.gov/research-funding/research-programs/kidney-precision-medicine-project-kpmp/faq) — NIH / NIDDK - [Kidney Precision Medicine Project](https://www.kpmp.org/) — Kidney Precision Medicine Project (NIDDK-funded) ### A caution about unproven 'stem cell' clinics _(No convincing evidence)_ **Some clinics market unapproved 'stem cell' or 'regenerative' treatments for kidney disease; these are not proven, are not FDA-approved for kidney disease, and can be unsafe as well as costly.** Because regenerative medicine sounds promising, a marketplace of clinics has emerged offering unapproved 'stem cell,' 'exosome,' or 'regenerative' treatments for serious conditions, including kidney failure — and these warrant real caution. The FDA has repeatedly warned that, aside from certain blood and immune-system uses, stem cell products are not approved to treat most diseases, and it has taken enforcement action against companies marketing such products (including for kidney failure) with unsubstantiated claims. These offerings are typically expensive, not covered by insurance, unproven, and can carry genuine safety risks (such as infection or other harms), while giving false hope and potentially delaying effective care. Legitimate experimental cell therapies are studied through regulated clinical trials, usually at no cost to participants and with oversight — a very different thing from a clinic selling a 'treatment.' Anyone considering such an option should discuss it with their kidney care team and be deeply skeptical of clinics that charge for unproven therapies or promise cures. > **Note:** Clinics selling unapproved 'stem cell' or 'regenerative' treatments for kidney disease are not offering proven care — discuss any such option with your kidney team and be very skeptical of paid 'cures.' **Sources:** - [FDA Warns About Stem Cell Therapies (consumer information)](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes) — U.S. Food and Drug Administration - [Important Patient and Consumer Information About Regenerative Medicine Therapies](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies) — U.S. Food and Drug Administration --- ## Complementary & Integrative Approaches Evidence-graded look at supplements and integrative approaches in kidney disease, with the kidney-specific safety flags — herbal toxicity and interactions, dangerous potassium/phosphorus loads, and contamination/mislabeling. Educational only. ### How to think about supplements with kidney disease _(No convincing evidence)_ **No supplement is proven to treat CKD, and the kidneys make supplements riskier than usual — some are directly toxic, deliver dangerous minerals, or interact with medicines — so always tell the care team what you take.** Supplements deserve special caution in kidney disease for reasons that go beyond the usual 'natural doesn't mean safe.' No dietary supplement is proven to treat or reverse CKD, and several factors make them riskier when the kidneys are impaired: some herbal products are directly toxic to the kidneys; many 'mineral-rich,' 'electrolyte,' or 'superfood' products carry high potassium or phosphorus loads that can be dangerous in CKD; reduced kidney function can let some supplement ingredients accumulate; and supplements can interact with the blood-pressure, kidney, and other medicines people with CKD rely on. On top of this, supplement quality and labeling are loosely regulated, so products can contain more, less, or different ingredients than the label states, and some have been found contaminated or adulterated. The single most important step is to tell every member of the care team — and the pharmacist — about any supplement before and during use, so it can be checked. Supplements should never replace proven CKD treatment, and many are best avoided altogether. > **Note:** Supplements are not a substitute for proven CKD treatment, and several are hazardous with kidney disease. Tell your care team and pharmacist about anything you take before using it. **Sources:** - [Herbal Supplements and Kidney Disease](https://www.kidney.org/kidney-topics/herbal-supplements-and-kidney-disease) — National Kidney Foundation - [Using Dietary Supplements Wisely](https://www.nccih.nih.gov/health/using-dietary-supplements-wisely) — NIH / NCCIH ### Herbal supplements that can harm the kidneys _(No convincing evidence)_ **Some herbal products can directly damage the kidneys or worsen CKD, and 'cleanses' or kidney 'detox' products are not proven; people with CKD are often advised to avoid herbal supplements unless cleared by their team.** Certain herbal supplements can be directly harmful to the kidneys, which is why people with CKD are frequently advised to avoid herbal products unless their care team has confirmed a specific one is acceptable. History offers a stark warning: some herbal products (for example those containing aristolochic acid) have caused severe, irreversible kidney damage, and various other herbs can stress the kidneys, raise blood pressure, or interact with medicines. Popular 'kidney cleanse,' 'detox,' or 'kidney support' products are not proven to help and may contain ingredients that are unsafe in CKD. The risk is compounded because herbal products are loosely regulated and can be contaminated or mislabeled. Importantly, a supplement that is fine for someone with healthy kidneys can be dangerous for someone with CKD, both because impaired kidneys handle ingredients differently and because of mineral and interaction issues. The safest approach is to treat herbal supplements as something to clear with the kidney care team and pharmacist first — not to try based on marketing claims. > **Note:** Some herbal supplements can cause serious, even irreversible, kidney damage. People with CKD are often advised to avoid herbal products unless specifically cleared by their care team. **Sources:** - [Herbal Supplements and Kidney Disease](https://www.kidney.org/kidney-topics/herbal-supplements-and-kidney-disease) — National Kidney Foundation - [Dietary and Herbal Supplements](https://www.nccih.nih.gov/health/dietary-and-herbal-supplements) — NIH / NCCIH ### Hidden potassium and phosphorus in supplements _(Established)_ **Many supplements marketed as 'mineral-rich,' 'electrolyte,' or 'green/superfood' powders contain high potassium or phosphorus, which can be dangerous for people with CKD who need to limit those minerals.** A specific and often-overlooked danger of supplements in CKD is their mineral content. Products promoted as 'electrolyte support,' 'high in minerals,' or 'superfood' and 'greens' powders can carry substantial amounts of potassium or phosphorus — exactly the minerals that people with more advanced CKD may need to limit because their kidneys cannot clear them well. In someone with reduced kidney function, a high-potassium supplement can contribute to dangerous hyperkalemia (with risk of serious heart-rhythm problems), and added phosphorus worsens the bone-mineral problems of CKD. Because supplement labels do not always make mineral content obvious, these loads can be 'hidden.' This is why people with CKD should scrutinize any supplement (and 'health drink' or protein/greens powder) for potassium and phosphorus and, ideally, run it past their renal dietitian or care team before use. Salt substitutes raise the same concern, since many are potassium-based. When in doubt, the care team or pharmacist can help judge whether a product's mineral content is safe given the person's kidney function and labs. > **Note:** 'Mineral-rich,' electrolyte, or greens/superfood supplements can deliver dangerous potassium or phosphorus in CKD — check the content with your care team or dietitian first. **Sources:** - [Herbal Supplements and Kidney Disease (potassium and phosphorus content)](https://www.kidney.org/kidney-topics/herbal-supplements-and-kidney-disease) — National Kidney Foundation - [Potassium in Your CKD Diet](https://www.kidney.org/kidney-topics/potassium-your-ckd-diet) — National Kidney Foundation ### Vitamins in CKD: which can help, which can harm _(Mixed evidence)_ **People with CKD sometimes need specific vitamins (often renal-formulated), but over-the-counter multivitamins can contain too much of some nutrients; vitamin needs are individualized and set by the care team.** Vitamins are a nuanced area in kidney disease. On one hand, CKD — especially with dietary restrictions or on dialysis — can lead to deficiencies of certain water-soluble vitamins (such as some B vitamins and, in some, vitamin C), and special 'renal' vitamin formulations are sometimes prescribed to address this safely. People with CKD may also need specific management of vitamin D, which the kidneys normally activate. On the other hand, ordinary over-the-counter multivitamins and high-dose single vitamins can be problematic: some contain amounts of fat-soluble vitamins (like vitamin A) that can build up to harmful levels when kidneys are impaired, or extra minerals (including potassium or phosphorus) that should be limited, and high-dose vitamin C can pose its own risks in CKD. The practical message is that vitamin needs in CKD are individualized and not a matter of grabbing a standard multivitamin — whether a person needs supplemental vitamins, and which kind, should be decided with the care team and renal dietitian based on their stage, diet, and lab results. > **Note:** Don't take standard over-the-counter multivitamins or high-dose vitamins in CKD without checking — some can accumulate to harmful levels or add unwanted minerals. Vitamin needs are individualized. **Sources:** - [Vitamins and Chronic Kidney Disease](https://www.kidney.org/kidney-topics/vitamins-chronic-kidney-disease) — National Kidney Foundation - [Healthy Eating for Adults with Chronic Kidney Disease (vitamins)](https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/healthy-eating-adults-chronic-kidney-disease) — NIH / NIDDK ### Cranberry, turmeric, and other popular products _(Mixed evidence)_ **Popular products like cranberry and turmeric are commonly asked about; evidence for kidney benefit is weak, and they carry interaction or mineral cautions, so they should be reviewed with the care team.** Several widely used products come up often in kidney disease. Cranberry (juice or supplements) is popular for urinary tract health, but evidence that it prevents urinary infections is limited and mixed, it is not a treatment for kidney disease, and cranberry can interact with the blood thinner warfarin while juices may carry sugar or oxalate considerations. Turmeric/curcumin is marketed for inflammation, but solid evidence for kidney benefit is lacking, it can interact with blood thinners and other drugs, high doses may not be well tolerated, and as a plant product it carries some potassium. Other commonly promoted items — various 'kidney support' blends, high-dose antioxidants, and assorted herbs — generally have weak or no evidence for CKD and the same regulatory and safety caveats. None of these should be relied on to treat kidney disease or substituted for proven care. The reasonable approach is the same throughout this section: discuss any such product with the care team and pharmacist, who can weigh the (usually limited) evidence against the interaction and mineral risks for that individual. > **Note:** Popular supplements like cranberry and turmeric have weak kidney evidence and real interaction/mineral cautions — review them with your care team and pharmacist before use. **Sources:** - [Dietary and Herbal Supplements (evidence and interactions)](https://www.nccih.nih.gov/health/dietary-and-herbal-supplements) — NIH / NCCIH - [Herbal Supplements and Kidney Disease (popular products and cautions)](https://www.kidney.org/kidney-topics/herbal-supplements-and-kidney-disease) — National Kidney Foundation --- _Educational synthesis from reputable public sources._ _Nurse Joy condition guide — educational reference. Not medical advice._